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Abstract 
Data with ordinal responses may be encountered in many research fields, such as social, 
medical, agriculture or financial sciences. In this paper, we present a case study on cumulative 
logit models with low frequency and mixed effects and discuss some strengths and limitations of 
the current methodology. Two plant pathologists requested our statistical advice to fit a 
cumulative logit mixed model seeking for the effect of six commercial products on the control of 
a seed and seedling disease in soybeans in vitro. In their attempt to estimate the model 
parameters using a generalized linear mixed model approach with PROC GLIMMIX, the model 
failed to converge. Three alternative approaches to solve the problem were examined: 1) 
stratifying the data searching for the random effect; 2) assuming the random effect would be 
small and reducing the model to a fixed model; and 3) combining the original categories of the 
response variable to a lower number of categories. In addition, we conducted a power analysis to 
evaluate the required sample size to detect treatment differences. The results of all the proposed 
solutions were similar. Collapsing categories for a cumulative/proportional odds model has little 
effect on estimation. The sample size used in the case study is enough to detect a large shift of 
frequencies between categories, but not for moderated changes. Moreover, we do not have 
enough information to estimate a random effect. Even when it is present, the results regarding 
the fixed factors: pathogen, evaluation day, and treatment effects are the same as the obtained by 
the fixed model alternatives. All six products had a significant effect in slowing the effect of the 
pathogen, but the effects vary between pathogen species and assessment timing or date.  
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1 
Chapter 1 - Introduction 
Categorical data analysis is a broad topic in statistics and is encountered in many research 
fields, such as social, medical, agricultural or financial sciences. John & Sons (2013) defined “A 
categorical variable has a measurement scale consisting of a set of categories.”  Ordinal 
responses are a common type of categorical data in which the variable of interest has a natural 
ordering. For instance, in sensory analysis, outcomes may be used to denote different levels of 
preference: “excellent”, “very good”, “good”, “neutral”, “poor”, and “very poor” (Snell, 1964). 
Surveys to address issues of public health measure frequency of certain symptoms or behaviors 
in categorical scales: “not at all”, “several days”, “more than half the days”, “nearly every day” 
(National Health and Nutrition Examination Survey, 2016). 
In this report, we discuss some of the strengths and limitations of current statistical 
methodologies to model ordered categorical data. In particular, cumulative logit mixed models to 
analyze experimental data with ordinal responses and low frequencies. To demonstrate the 
current statistical approach, we analyzed a real dataset as a case study. Two plant pathologists 
one from the School of Agronomy, Buenos Aires University, Argentina; and the other at 
Northwest Missouri State University conducted an experiment to evaluate the effect of three 
agrochemicals in the development of Pythium damping off: a seed and seedling disease of 
soybean caused primarily by several species of the oomycete pathogen Pythium spp.. Damping-
off is characterized as the weakening or killing of seeds and seedlings (Kirkpatrick, et al. 2006). 
Thus, the response variable in the experiment was an ordinal rating with six categories, where 0 
= “healthy seed (germinated)”, 1 = “geminated with a small necrosis” and so on, up to 5= “dead 
seed (non-germinated)” (Jiang, et al. 2012).  
2 
The researchers attempted to fit a cumulative logit mixed model using GLIMMIX 
procedure of SAS® to determine the effect of six treatments (three products at two application 
rates) in protecting soybean seeds from infection by three Pythium species: P. aphanideramatum, 
P. irregulare, and P. ultimum. Disease rating assessments were carried out at 5 and 21 days after 
inoculation. In their attempts to fit the cumulative logit model using PROC GLIMMIX, the 
model failed to converge so they requested our statistical expertise to help. This report describes 
the process that led us to the answer to their question by fitting a cumulative logit mixed model 
and discussing the strengths and limitations of such modeling strategy to analyze ordinal 
categorical data. Although SAS® GLIMMIX procedure enables estimation of model parameters 
for multinomial data, it may encounter several issues, especially those related to sample size and 
particularities of the observed data. In the present study, strong assumptions and compromises 
were made to obtain a response to the question of what product works best on controlling 
Pythium damping off. 
The rest of this chapter presents the details of the experimental design and the data 
collection methodology. Chapter 2 introduces the statistical theory behind the modeling 
approaches and the methods used for estimation. On chapter 3, we present and discuss the results 
of the analysis. On chapter 4, we justify some of the compromises and assumptions needed to 
obtain answers by way of power calculations and a simulation experiment. Finally, the 
conclusion of this study is presented in chapter 5.     
 1.1 Experimental Design and Data Collection 
Data provided by Drs. Carmona and Perez-Hernandez were used in this study. Details of 
the experiments are mentioned elsewhere (Carmona et. al., 2017). Briefly, seeds of the soybean 
cultivar NIDERA A5009RG, which is glyphosate-tolerant and susceptible to Pythium spp., were 
3 
surface-sterilized and treated with either a product or a control. Two hundred grams of seeds for 
each treatment were used in the experiment and they were sterilized with 1% sodium 
hypochlorite for 1 minute before receiving the treatment, and then rinsed in sterile water twice. 
Three species among a collection of Pythium isolates, i.e. specimens, that were previously 
recovered from soybean soils in different surveys in the province of Buenos Aires, Argentina 
were randomly selected such that one isolate of each Pythium species: P. aphanidermatum, P. 
irregulare, and P. ultimum were grown on potato dextrose agar (PDA; Merck). Before using 
these isolates, they were kept at 20ºC for seven days in darkness. There were six different 
combinations of products such that the experiment had seven treatments levels including the 
control (seeds treated with water only).  
 Two commercial phosphite-based products, traded as foliar fertilizers were provided by 
Spraytec Fertilizers, LDTA; and the other, the fungicide Maxim widely used as a protectant 
soybean seed treatment for Pythium, was provided by Syngenta. Phosphite-based products were 
applied at the standard commercial rate and double this rate, whereas the fungicide rate was what 
the manufacturer recommended. The seven treatments from hereafter are MnPhi 200, MnPhi 
400, Kphi 200, Kphi 400, MnPhi 200 + Maxim and Maxim 100. In a 500 ml Erlenmeyer flask 
plus 2% of sterile water, a slurry of each treatment was assigned to 200 g of seeds and similarly, 
untreated seeds were treated with disinfected distilled water. A 25 ml of PDA (one 6-mm 
diameter mycelial disc) was taken from 7-days stored cultures of the Pythium species to the 
center of 9-cm plastic petri dish. Next, from each treatment including the control treatment, five 
seeds were randomly assigned and placed at about 4-cm from the mycelial disc in a petri dish. 
All petri dishes were arranged on a bench in darkness at 24°C+/-0.2°C. There were ten petri 
dishes per treatment and pathogen combination. Five days later, each seed was evaluated to 
4 
determine the seeds’ germination and necrosis in the radicle. The severity of the disease was 
rated at six levels: 0 = “Healthy seed, germinated”, 1= “Germinated but with tip of radicle 
showing necrosis”, 2 = “Germinated seed with tip of radicle showing necrosis to a greater 
extent”, 3 = “Germinated seed with advanced necrosis and with less overall growth”, 4 = 
“Germinated seed, but radicle completely dead”, and 5 = “Dead seed”. This severity scale is a 
modified version of the one proposed by Jiang et al. (2012). After that, the severity of the disease 
on each seed was reevaluated on day twenty-first (Carmona et al, 2017).  
We have mentioned that the researchers were interested in determining the effectiveness 
of the formulations to control the disease in vitro. According to their experiment description, the 
response variable (disease severity) was measured on an ordered scale with six categories. The 
treatments were applied to groups of seeds, but the pathogen inoculation was done at petri dish 
level, so the smallest experimental units were the petri dishes. We considered them as random 
effects because they represent a sample of the population of all petri dishes. In contrast, the 
disease was rated for each seed so they are the observational units. The researchers were 
interested in Pythium in general, but also in whether the effect may vary between isolates. In 
particular, differences between the three selected species of Pythium (P. aphanidermatum, P. 
irregulare, and P. ultimum), thus we consider the pathogen species as a fixed effect.  Finally, 
disease severity on seeds was evaluated at five and twenty-one days after inoculation.  We 
considered these as repeated measures and conceptualized the study design with the plan plot in 
figure 1.1. 
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Figure 1.1 Plan plot of the study design and treatment structure. 
 
 1.2 Data Description 
According to the experiment described in the previous section, we have a three-way 
factorial treatment structure with repeated measurement on days five and twenty-one. The three-
fixed effect factors are the seven treatments, the two evaluations and the three Pythium species. 
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The random effect is the ten petri dishes per treatment pathogen combination that should be 
treated as the experimental units. In figure 1.2, we display the frequency distribution of the 
disease severity by Pythium species at each evaluation timing.  
 
Figure 1.2 The observed counts for each category of the disease severity of each pathogen 
(column) by each day (row). 
As shown in figure 1.2, germinated seeds (severity 0) had the lowest frequency in all 
Pythium species except for the first evaluation of P. aphanidermatum. It is also shown that the 
first and second levels of disease severity had zero counts in the second evaluation of P. 
irregulare and P. ultimum. It appears that there tends to be less germination in these groups. 
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Overall, we notice that at the second evaluation, all seeds tend to be in worst shape, i.e., higher 
categories are observed, for all Pythium species and the third pathogen P. aphanidermatum 
seems to be less resistant to the products than the other two. Seeds infected with it have a higher 
frequency of germination in both evaluations. Furthermore, we notice that for all species and 
both evaluations, some categories of disease severity have very small counts. In the following 
plots (figures 1.3 and 1.4), we present the interaction between the three species and the two 
evaluations in each treatment for the observed counts. 
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Figure 1.3 Interaction plots of empirical probabilities (nij/Ni) where nij is number of 
observed counts in jth category of the disease severity for ith treatment group and Ni is the 
total number of seeds for each treatment group of each treatment show interactions 
between Pathogen (color) and Day (symbol) effects per treatment.  
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Figure 1.4 Interaction plots of empirical probabilities (nij/Ni) where nij is number of 
observed counts in jth category of the disease severity for Control group and Ni is the total 
number of seeds for Control group show interactions between Pathogen (color) and Day 
(symbol) effects. 
From observing figure 1.3, it is evident that across treatments, the distribution of the 
frequencies by disease severity is not constant for each pathogen species; and the change from 
day 5 to day 21 also depends on the infecting species. In conclusion, the treatment effect varies 
depending on the Pythium isolate and when the evaluation was made. For example, for treatment 
MnPhi 200, the empirical probabilities of the severity levels for P. irregulare pathogen are not 
the same for the two different evaluations. Also, we can see that the effect of P. irregulare at 
Day 5 for category 1 is different across treatments and similar conclusions can be made for the 
rest of treatments and species. Moreover, in figure 1.4 for the Control treatment (untreated 
seeds), clearly dead seeds have the highest empirical probability for all three Pythium species in 
the two evaluations. Seeds with P. irregulare pathogen seem to have some natural resistance. 
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Thus, we believe that there might be a significant interaction between pathogen, treatment and 
day effects on the probabilities of each disease severity level.  
From the experimental structure, it is evident that a multinomial generalized mixed model 
is necessary here. Moreover, the preliminary data exploration indicates that interaction effects 
need to be considered to account for the differential effects shown in figures 1.3 and 1.4. 
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Chapter 2 - Generalized Linear Mixed Models Methods for 
Multinomial Data 
 2.1 An Overview of Multinomial Data  
According to John & Sons (2013), a categorical variable measures a phenomenon as a 
result of a set of categories, or possible outcomes. Moreover, categorical variables that have a 
natural ordering, such as disease rating (“asymptomatic”, “mild symptoms”, “moderate 
symptoms”, “severe symptoms”) or opinion rating (“strongly agree”, “agree”, “neither agree nor 
disagree”, “disagree”, “strongly disagree”), are called ordinal variables. In contrast, variables 
with unordered scales, such as eye color, or animal species, are called nominal. Here we focus 
our discussion on models for ordinal response variable. Categorical variables with two possible 
outcomes, also known as binary outcomes, are called binomial data in statistical terminology 
because they are assumed to follow a binomial distribution. Moreover, categorical variables with 
more than two possible outcomes are called multinomial data for a similar reason. 
 2.1.1 Multinomial Distribution 
Formally, multinomial variables are defined as data resulting from N independent trials; 
each trial has more than two possible outcomes. Let J denote the number of possible outcomes, 
or response categories on these trials and define Y = (y1, y2, . . . , yJ), where yj = number of trials 
with outcome “j”. Thus, Y is the observed counts in J different categories after N trials or the 
observed counts of J different values for some categorical variable. If the probability of 
observing each of the categories stays constant for the N trials, then Y is said to follow a 
multinomial distribution. Define the probabilities of the observed outcome from each category to 
be as {π1, π2, …., π𝐽}, where ∑ π𝑗
𝐽
𝑗=1  =1. Then, the multinomial probability mass function is: 
12 
f (n1, n2, …n𝐽) = 
𝑁!
n1!n2! …n𝐽!
 π1
n1π2
n2 ⋯ πJ
nJ
,                                                                   (2.1) 
which refers to the probability that exactly n1observations fall in category 1, n2 observations fall 
in category 2, …., and n𝐽 observations fall in category J, where ∑ n𝑗
𝐽
𝑗=1 =N. Any count n𝑗  in any 
category j has a marginal distribution binomial with mean nπ𝑗 and variance nπ𝑗 (1- π𝑗 ), i.e., a 
probability of success π𝑗 (Agresti, 2013). 
 2.1.2 Multinomial Models 
For binary data, logistic regression is the most popular model and a generalization of this 
can be extended to multinomial data modeling. For ordinal multinomial data, the preferred model 
is the cumulative logit models also known as proportional odds models. Prior to generalized 
linear mixed models, ordinal categorical variables were often coded as numeric values and 
analyzed as an approximate normal data with normal distribution regardless of the normality 
assumption. This leads to two problems, what the right numeric code should be and what the 
interpretation of the average rating means. For example, if the numeric code of an ordinal 
response is 0, 1, …, 5, what does an average rating 2.5 mean? We may propose many different 
ways to answer these questions; some of these answers could lead to very different conclusions 
about the relationship between predictors and our ordinal response. The models considered focus 
on π𝑗 , the probabilities associated with each category rather than a possibly ambiguous 
numerical code (Stroup, 2013). 
 2.1.2.1 Models Using Cumulative Logits 
Proportional odds models are commonly used to model ordinal multinomial response 
with a linear predictor using a logit link function. The cumulative logit functions for generalized 
linear mixed models are as follows: 
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Ƞ𝟏=log (
π1
1−π1
) =  α1 + 𝑋𝛽 + 𝑍𝑏 
Ƞ𝟐=log (
π1+π2
1−(π1+π2)
) =  α2 + 𝑋𝛽 + 𝑍𝑏                                                                          (2.2) 
. 
. 
. 
Ƞ𝐉−𝟏=log (
π1+π2+⋯+π𝐽−1
1−(π1+π2+⋯+π𝐽−1)
) =  α𝐽−1 + 𝑋𝛽 + 𝑍𝑏,  
where j =1, 2…., J, being the number of the response categories, α𝑗  is the intercept of the jth 
category, 𝑋𝛽 represents the linear predictor for the fixed effects and/or covariates/predictors 
coefficients; and 𝑍𝑏 denotes the random part of the linear model with the vector 𝑏 consisting of 
the random effects. Therefore, J-1 equations are needed for a multinomial distribution with J 
categories.  
Alternatively, we can write the proportional odds model: 
Logit P(Y ≤ j) = Logit 𝛾𝑗 = log (
𝛾𝑗
1−𝛾𝑗
) = α𝑗 + 𝑋𝛽 + 𝑍𝑏                                             (2.3) 
where 𝛾𝑗 = P(Y ≤ j) is the probability that observation y falls in category j or lower, 𝛾1≤ 
𝛾2≤…...≤ 𝛾𝐽−1≤ 𝛾𝐽  ≤ 1 and, α𝑗 + 𝑋𝛽 + 𝑍𝑏 is the same as before.. The estimated probabilities are 
π̂𝐣  = 𝛾𝐣 − 𝛾𝐣−𝟏 , j=2, . . . , J-1, and π̂𝟏  = 𝛾𝟏 where 𝛾𝐉 =1.  
We note that the intercept (α𝑗) is the only parameter that changes between categories 
whereas the effects, fixed or random, stay the same on all response cumulative probabilities.  
The sign of the fixed effect indicates the probability of the response of being in the lower 
categories or the higher ones. If the sign is positive, this indicates that as the level/value of a 
predictor increases, the response is more likely to fall in lower categories. On the other hand, if 
the sign is negative, it indicates that as the level/value of a predictor increases, the response is 
more likely to fall in higher categories.  
14 
The difference between any two treatments effects is the log odds ratio. Exponentiating 
this difference yields an estimate of the odds ratio (Stroup, 2013).  
In categorical data models, odds ratio is commonly used as a measure of the association 
between a categorical response variable and predictors (Agresti, 2007). We will use two-by-two 
contingency tables to illustrate the concept. The odds of success can be defined as 
  Odds =  
π
1−π
,                                                                                                                  (2.4) 
where π is the probability of success, i.e., the probability that the desired outcome occurs. The 
higher the odds, the higher the chance of a successful outcome. If we have odds1 as odds of 
success in row 1 and odds2 as odds of success in row 2, where row 1 and row 2 represent 
categories of a predictor in the two-by-two contingency table, then the odds ratio is: 
  Ɵ = 
odds1
odds2
 =  
π1/(1−π1)
π2/(1−π2)
                                                                                                   (2.5) 
For the interpretation of the odds ratio, Ɵ = 1, this means that the two variables are 
independent and that π1 = π2. In contrast, if Ɵ > 1, then the odds of success in row 1 are higher 
than in row 2. On the other hand, if Ɵ < 1, then the odds of success in row 2 are higher than in 
row 1. The farther the odds ratio is from 1, the stronger the association between variables.  
 
 2.2 Estimation with Generalized Linear Mixed Models  
In this section, we present a brief discussion about model parameter estimation with 
generalized linear mixed models. Generalized linear mixed models (GLMM) are considered 
general models encompassing other models that are GLMM special cases, namely, the linear 
models (LM), generalized linear models (GLM) and linear mixed models (LMM). The GLMM 
consists of the following components: 
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• Linear predictor: Ƞ  = 𝑋𝛽 + 𝑍𝑏, where X is an N x p design matrix with p 
parameters in the linear predictor and N is the number of observations, 𝛽 is a p x 1 
vector of fixed effects model parameters and b is a vector of the random model 
effects. 
• Link function: Ƞ = g(μ|b). 
• Distribution: b ~N (0, G) 
• Distribution or quasi-likelihood of the observations conditional on the random 
effects, y|b: E(y|b) = μ|b. 
 In GLMM, we need to estimate the parameters for the fixed effects 𝛽, any components 
of Var(y|b), b and the variance-covariance component G. A traditional maximum likelihood 
approach requires that the observations conditional on the random effect belong to the 
exponential family or have a quasi-likelihood. However, when maximizing the likelihood, 
further simplification of the marginal likelihood that involves the product of Gaussian and 
exponential family or quasi-likelihoods are not always possible. Therefore, we need some 
approximation instead of the direct maximization. This can be achieved using two approaches: 1) 
linearization: the pseudo-likelihood method; and 2) integral approximation: Laplace 
approximation and adaptive Gauss-Hermite quadrature (Stroup, 2013).  
An advantage of using pseudo-likelihood (PL) is that the pseudo-likelihood assumes that 
the approximating function is close to the structure of the Gaussian log-likelihood so that we can 
use LMM estimating equations for the linear predictor effects and the covariance components. 
PL’s estimating equations can be considered as the general estimating equations for all LM, 
GLM, LMM and GLMM. Additionally, PROC GLIMMIX by default uses RSPL a pseudo-
likelihood implemented with the restricted –or residual– maximum likelihood (REML) version 
for the covariance estimation, details can be found in Stroup, 2013 and SAS/STAT® 9.2 User’s 
Guide. However, PL does not always work. Integral approximation is then used in situations that 
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do not work with PL. Laplace and Quadrature approximations have the advantage that they focus 
on the actual likelihood where the statistics are well defined which is not true for pseudo-
likelihood. This only becomes an issue with non-Gaussian data (GLMM), which is our case. 
Thus, in this report we chose integral approximation. For quadrature approximation, increasing 
the number of quadrature points results in more accurate approximation. Quadrature 
approximation with a single point gives an identical result to Laplace approximation. In 
comparison to PL, Laplace has less bias for small samples. In addition, we have a small number 
of Bernoulli trials per units of observations of non-Gaussian data with mixed effects and repeated 
measures and Stroup 2013 suggests Laplace approximation for this type of cases. Thus, in this 
paper, we focus on Laplace approximation given that quadrature approximation is 
computationally more intensive. 
In the following section, we present a short description of Laplace approximation used by 
the GLIMMIX procedure in SAS® software, which is the method and software used for next 
chapter’s data analysis. 
 2.2.1 Laplace Approximation in PROC GLIMMIX 
Let the marginal distribution of the data be 
P(y) = ∫ 𝑝(𝑦|𝛾, 𝛽, Ф, Ɵ)𝑝(𝛾|Ɵ∗)𝑑𝛾 
        = ∫ exp {𝑙𝑜𝑔{𝑝(𝑦|𝛾, 𝛽, Ф, Ɵ∗)} + 𝑙𝑜𝑔{𝑝(𝛾|Ɵ∗)}}𝑑𝛾                                             (2.7) 
        = ∫ exp {𝑐𝑙𝑓(𝑦, 𝛽, Ɵ, 𝛾)}𝑑𝛾, where 𝛽 is a vector of the fixed effects, Ɵ is a vector of 
covariance parameters that includes the G side parameters and Ф a possible scale parameter and 
Ɵ∗is a vector of the G side parameter. 
With large 𝑐l, the Laplace approximation is  
L (𝛽, Ɵ, 𝛾, 𝑦) = (
2𝜋
𝑐𝑙
)
𝑛𝛾
2   |−f ′′(𝑦, 𝛽, Ɵ, 𝛾)|−
1
2 𝑒𝑐𝑙𝑓(𝑦,𝛽,Ɵ,?̂?),                                                (2.8) 
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where 𝑛𝛾is the number of elements in 𝛾 and f
′′is the second derivative matrix  
f ′′(𝑦, 𝛽, Ɵ, 𝛾) =  
𝜕2𝑓(𝑦,𝛽,Ɵ,𝛾)
𝜕𝛾𝜕𝛾
 |?̂? and 𝛾 satisfies  
𝜕𝑓(𝑦,𝛽,Ɵ,𝛾)
𝜕𝛾
= 0. 
For Laplace parameter estimation, the objective function in GLIMMIX procedure is -
2log{L (𝛽, Ɵ, 𝛾, 𝑦)}. In GLIMMIX procedure, when processing the data by subject, as the 
number of subjects and observations per subject increases, the chance of having small sample 
bias of Laplace estimator decreases SAS® (SAS Institute Inc.). 
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Chapter 3 - Data Analysis  
In this chapter, we present the data analysis and results of the case study. Different 
approaches were followed to find the most appropriate model that accounted for the ordinal 
response and the required mixed effect. All models were fitted using GLIMMIX procedure in 
SAS®. We start in the next section by defining the GLMM that would represent the experiment 
and data collection best. However, we make evidence in the subsequent sections limitations 
caused by sample size and computational methodologies, forced us to adjust the model 
assumptions. 
 
 3.1 The Statistical Model  
 In chapter 1, we established that the objective of the experiment was to evaluate the 
effectiveness of some commercial products to control the disease development of specific 
species of Pythium. We have a response variable (disease severity) measured in an ordered scale 
with six categories, a treatment factor that was applied to groups of seeds and a pathogens factor 
that was applied at petri dish level. Petri dishes are the smallest experimental units and were 
assumed as random because we want to generalize our conclusions to the overall population of 
the petri dish. The observational units are the seeds. The pathogens factor is assumed fixed 
because Drs. Carmona and Perez-Hernandez were interested in making conclusions applicable to 
these three species of Pythium (P. aphanidermatum, P. irregulare, and P. ultimum) in specific 
first, and later generalize them if possible. Finally, seeds were evaluated on two different dates. 
We could have considered these as repeated measures, but with only two measurements and for 
simplicity, Time effect was modeled as a third fixed factor. 
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The number of seeds for each category of the response variable and each combination of 
treatment, pathogen and day is represented by: 
Yijkl = number of seeds in the jth category of the disease rating, ith treatment, kth 
pathogen, lth day and mth petri dish where j=0, 1, …5; i =1,2,…,7; k= 1,2,3; l= 1,2; 
m=1,2,…,10.    The conditional distribution of the response variable (counts by disease severity) 
given the random effect (dish) is multinomial. Since our response variable is ordinal, we 
assumed a cumulative logit model with mixed effects, where the petri dish was represented by a 
random variable with normal distribution N(0, 𝜎𝐷
2). We defined the cumulative logit as 
Logit(P(Y≤j)) = Ƞj= 𝜶j + Xβ + Zb;                                                                             (3.1) 
where j=0,1,2,3,4 and the proportional odds model used as follows: 
Logit(P(Y≤j)) = Ƞijklm = 𝜶j + Ti + Fk+ Dayl + Dishm (Ti*Fk) + TiFk + TiDayl + FkDayl + 
TiFkDayl                                                                                                                                      (3.2)   
where 𝜶j is the intercept for the jth link and Ti, Fk, Dayl and Dishm denote the ith treatment, kth 
pathogen, lth day and mth petri dish effects respectively. 
A 3-way factorial treatment structure with interaction was chosen based on the evidence 
of factor interactions detected during the exploratory data analysis. Furthermore, we set the 
reference category of treatment, pathogen and day as Control, P. ultimum, and Day 21, 
respectively. Petri dishm ~ iidN (0,𝜎𝐷
2) represents the petri dishes. 
Although the model above seemed reasonable at the time, we soon discovered that SAS® 
PROC GLIMMIX could not fit the model. Next, we discuss the approach we took to understand 
the limitations of the data and the statistical models and how we were forced to make stronger 
assumptions to obtain some results. 
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 3.2 Data Analysis and Model Fitting  
In this section, we present the gradual processes that we followed to achieve the objective 
of this study. Once we discovered that we did not achieve convergence or reasonable estimates 
for the GLMM defined in the previous section, we looked for alternatives.  
As we mentioned in chapter 1 that Drs. Carmona and Perez-Hernandez tried to fit a 
cumulative logit model in GLIMMIX using a response variable with six categories but 
encountered convergence problems. First, the researchers had labeled all petri dishes from one to 
ten for each combination of treatment and pathogen. Petri dishes are not blocks in this 
experiment, but different experimental units. We coded petri dishes as nested factor in both 
treatment and the pathogen factors to guarantee SAS® fitted the correct model. Secondly, as we 
discussed in section 2.2.1, GLIMMIX default method, Pseudo-likelihood approximation (PL) is 
not always applicable. PL does not approximate the likelihood properly for cases, like binomial 
or multinomial GLMMs with a small number of trials per unit of observation (Stroup, 2013). 
Thus, we used Laplace approximation since it is the method of choice with non-Gaussian 
GLMM data and repeated measures.  
The severity of the disease was evaluated on two different days on the same petri dishes 
so that we consider these as repeated measures. To account for possibility of the correlation due 
to repeated measures with non-Gaussian data and Laplace approximation, we used the first order 
auto-regression model AR (1) but GLIMMIX couldn’t estimate the random effects. Since the 
variability might differ between evaluations, we tried a heterogeneous first-order autoregressive 
structure ARH (1). Again, the variance components were not estimable by Laplace or other 
GLIMMIX methods.  
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As we mentioned in section 3.1, with two time points, we decided to assume that the day 
effect was fixed and we kept only the petri dish effect as random. Thus, we fitted a three-way 
factorial treatment structure with mixed effects. When we tried to fit the model with Treatment, 
Pathogen, Day as fixed effects and Petri dish as a random effect, we obtained problematic results 
again. Even though GLIMMIX procedure convergence criterion was satisfied and we obtained 
estimates for the fixed effects, we found a zero estimate for the random effect (petri dish) with 
undetermined standard error. To capture the random effect of the petri dish closely, we fitted 
two-way cumulative logit model with mixed effects for each day and each pathogen separately 
using Laplace method in GLIMMX procedure and the results illustrated in tables 3.1 and 3.2.  
 DAY 5 DAY 21 
Estimate 0.1644 0 
Standard Error 0.1208 . 
Table 3.1 Petri dish random effect estimate for fitting cumulative logit model with mixed 
effects separately by each Day.  
 
 P. aphanidermatum P. irregulare P. ultimum 
Estimate 0 0 0.1147 
Standard Error 0.07719 . 0.09726 
Table 3.2  Petri dish random effect estimate for fitting cumulative logit model with mixed 
effect separately by each Pathogen. 
Table 3.1 shows that when fitting the mixed model separating the data by Day, only the 
model for the first evaluation (Day 5) was estimable. The second measurement, day twenty-first 
has the same problem we had with the full mixed model. We could not obtain a valid estimate 
for the random effect. A similar situation occurred when trying separated fits for each of the 
pathogens (Table 3.2). We could not estimate the petri dish random effect on Irregulare. We 
present these results for day 5 and P. ultimum in the next section.   
22 
  The model we defined in equations 3.1 and 3.2 assumes our response variable follows a 
multinomial with N=5 and six possible categories. Even with the ten replicates of the conditional 
distribution, five seeds per trial seemed small for a multinomial data with six categories, so we 
decided to fit a fixed effect model with 3-way factorial treatment structure removing the petri 
dish effect regardless of the random effect. Under this model, we observe fifty seeds per trial 
instead of five. In other words, by making the assumption that the effect of the petri dish is not 
significant. Our multinomial data moves from N=5 to N= 50. The ANOVA shell associated with 
this model is: 
Source of Variation DF 
Treatment 6 
Fungus 2 
Day 1 
Treatment* Fungus 12 
Day* Fungus 2 
Treatment* Day 6 
Treatment*Fungus*Day 12 
Error 2054 
Total 2095 
Table 3.3 ANOVA shell for the three-way cumulative logit fixed model. 
In addition, we fitted two-way cumulative logit model with fixed effects for each day and 
each pathogen separately to compare the results with the previous two-way cumulative logit 
mixed model results. This comparison could provide insight into whether or not our results of 
three-way cumulative logit model with fixed effects can be reliable. If the smaller simpler 
models show little differences or gain from the inclusion of the random petri dish effect, then 
maybe 𝜎𝐷
2 is not significantly different than zero, even if we cannot prove it. The results are 
presented in the next section.  
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Figure 1.4 shows another peculiarity of the data that we exploit in our pursuit of an 
estimable model. The Control treatment (untreated seeds) has very low variability. In the first 
evaluation, most seeds tend to be non-germinated which results in high frequency at categories 4 
and 5, and zero frequencies in the remaining categories. Similar to what happens in logistic 
regression when only success or only failures are observed, we suspect some computational 
problems may arise from observing all values in only one category, or when estimated 
probabilities are very close to the boundaries of the parameter space. Moreover, figure 1.3 shows 
that treated seeds, regardless of the treatment, fairly much better than the control group. For these 
reasons, we tried estimating the models removing the control treatment from the analysis. 
Results are presented in section 3.3.4.  
Finally, besides simplifying the linear model, we also tried reducing the number of 
parameters to estimate, since we have six categories of the response variable with low 
frequencies, we tried collapsing the categories of the response variable in two different ways and 
estimate the model from equations 3.1 and 3.2 in GLIMMIX but now with J =3 categories as in 
Carmona, et. Al. 2017, and with J = 2 categories to reduce the problem to a more traditional 
logistic regression. These results will be discussed in section 3.3.5. 
 3.3 Results 
First, we discuss the results of the two-way cumulative logit mixed model on the first 
evaluation of the severity of the disease and on P.ultimum in section 3.3.1. Then we present the 
results of the three-way cumulative logit fixed model in section 3.3.2. Additionally, we present 
the results of the two-way cumulative logit fixed model on the first evaluation of the severity of 
the disease and on P. ultimum in section 3.3.3. 
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 3.3.1 Two-way cumulative logit mixed model 
When we fitted mixed model on the first evaluation, we found that the effect of each 
treatment was different for each pathogen which implies heterogeneous association relating the 
response probabilities to the linear predictor and we found that the interaction between treatment 
and pathogen is significant. We also conducted pairwise comparison tests using Bonferroni 
correction and obtained the estimated odds ratios to compare the differences for the effects of 
treatments at each pathogen in SAS as shown in the following tables. Also note that the odds 
ratios in the following tables are considered to compare treatments in the columns to treatments 
in the rows. 
 3.3.1.1 The odds ratios on the first evaluation 
For P. aphanidermatum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.2170 -      
Maxim 100 27.2739 125.65 -     
MnPhi 200 
+ Maxim 
2.1718 10.0020 0.07960 -    
MnPhi 400 0.2185 1.0065 0.008010 0.1006 -   
Control 5130.38 23628 188.04 2362.31 23475 -  
MnPhi 200 0.2892 1.3319 0.01060 0.1332 1.3233 0.000056 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.4 Odds ratios for P. aphanidermatum at the first evaluation of the mixed model.   
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For P. irregulare:  
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.1164 -      
Maxim 100 2.1286 18.2847 -     
MnPhi 200 
+ Maxim 
0.1483 1.2737 0.06966 -    
MnPhi 400 0.01136 0.09760 0.005338 0.07663 -   
Control 26.4445 227.16 12.4233 178.34 2327.37 -  
MnPhi 200 0.01832 0.1574 0.008607 0.1236 1.6124 0.000693 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.5  Odds ratios for P. irregulare on the first evaluation of the mixed model.  
For P. ultimum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 1.0311 -      
Maxim 100 2.8171 2.7321 -     
MnPhi 200 
+ Maxim 
0.3561 0.3454 0.1264 -    
MnPhi 400 0.1798 0.1744 0.06384 0.5049 -   
Control 1503.78 1458.41 533.80 4222.43 8362.13 -  
MnPhi 200 1.5314 1.4852 0.5436 4.2999 8.5155 0.001018 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.6  Odds ratios for P. ultimum on the first evaluation of the mixed model.   
Some of the estimated odds ratios are significant and some are not. We can see all 
products are better than the Control treatment and all of them work better for P. aphanidermatum 
than the other species followed by P. ultimum. The best product of being resistant to P. 
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aphanidermatum are Kphi 400, MnPhi 400 and MnPhi 200 and the effect of them is the same 
since the odds ratio of these effects is not significant. For P. ultimum, the most effective products 
are MnPhi 400 and MnPhi 200 + Maxim and they have the same effect and most of the rest of 
the products have the same effect. For P. irregulare, the most resistant products are MnPhi 400 
and MnPhi 200. Since the odds ratio of them is not significant, they have the same effect. 
Overall, the least effect on controlling all species is Maxim 100 when comparing with untreated 
seeds (Control). Also, the most resistant product to all pathogens seems to be MnPhi 400.  
 3.3.1.2 The odds ratios on P. ultimum 
In addition, as we mentioned in section 3.2 that we fitted cumulative logit model with 
mixed effect by each pathogen and we could estimate the random effect and obtained results at 
each evaluation on P. ultimum as the following tables: 
For the first evaluation: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 1.0556 -      
Maxim 100 3.6299 3.4388 -     
MnPhi 200 
+ Maxim 
0.3333 0.3157 0.09181 -    
MnPhi 400 0.1814 0.1718 0.04997 0.5442 -   
Control 14904 14120 4106.06 44724 82177 -  
MnPhi 200 1.7286 1.6377 0.4762 5.1871 9.5309 0.000116 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.7 Odds ratios for the first evaluation of mixed model for P. ultimum.   
As we see in table 3.7 that all treatments are better than the control treatment for the first 
evaluation. Treatment Kphi 200, Kphi 400, Maxim 100, MnPhi 200 and MnPhi 200 + Maxim 
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have the same effect. Treatment MnPhi 400 seems to be the most effective treatment on the first 
evaluation since it has the highest odds ratio in comparison with untreated seeds and the results 
agrees with what we found in the previous section. 
For the second evaluation: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 3.7983 -      
Maxim 100 7.9873 2.1029 -     
MnPhi 200 
+ Maxim 
1.0350 0.2725 0.1296 -    
MnPhi 400 4.4428 1.1697 0.5562 4.2927 -   
Control 69411726 18274608 8690225 67066779 15623487 -  
MnPhi 200 1.7528 0.4615 0.2194 1.6936 0.3945 2.525E-8 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.8  Odds ratios for the second evaluation of mixed model for P. ultimum.   
As we see in the second evaluation, all treatments seem to be ineffective with P. ultimum 
when comparing to untreated seeds. Clearly the treatment efficacy is affected by the time factor 
so that researchers may have to consider this point and apply treatments several times to keep the 
seeds safe.  
 3.3.2 Three-way cumulative logit fixed model  
Furthermore, we fitted cumulative logit model as 3-way factorial treatment structure with 
the fixed effects ignoring the petri dishes effect in GLIMMIX with the control treatment as the 
reference level. However, we didn’t obtain the degrees of freedom for the ANOVA shell that we 
expected in the previous section as the following table:  
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Effect Num DF Den DF F-value P-value 
Treatment 1 2054 0 1 
Pathogen 2 2054 0 1 
Day 1 2054 0 1 
Treatment* Pathogen 2 2054 0 1 
Day* Pathogen 2 2054 0 1 
Treatment* Day 1 2054 0 1 
Treatment*Pathogen*Day 4 2054 0 1 
Table 3.9 Type III test of fixed effects model with the control treatment as the reference 
level.   
As we see in table 3.9 GLIMMIX procedure with the control treatment as the reference 
level provides different degrees of freedom than table 3.3 for the effects, zeros for the F-values 
and ones for the p-values. This leads us to change the reference level to MnPhi 200 and consider 
this for all results in this chapter. 
Now we fitted cumulative logit model as 3-way factorial treatment structure with the 
fixed effects and MnPhi 200 as the reference level. We found that the three-way interaction term 
is significant as shown in table 3.10. 
Effect Num DF Den DF F-value P-value 
Treatment 6 2054 59.68 <.0001 
Pathogen 2 2054 0 0.9988 
Day 1 2054 0.02 0.8888 
Treatment* Pathogen 12 2054 13.86 <.0001 
Day* Pathogen 2 2054 0 0.9993 
Treatment* Day 6 2054 17.98 <.0001 
Treatment*Pathogen*Day 12 2054 6.75 <.0001 
Table 3.10 Type III test of fixed effects model with the MnPhi 200 treatment as the 
reference level.   
We also conducted pairwise comparison tests using Bonferroni correction and obtained 
the estimated odds ratios to compare the differences for the effects of treatments at each 
pathogen and each evaluation in SAS as shown in the following tables. 
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For the first evaluation at P. aphanidermatum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.2358 -      
Maxim 100 62.1792 263.66 -     
MnPhi 200 
+ Maxim 
2.1366 9.0595 0.03436 -    
MnPhi 400 0.2400 1.0178 0.003860 0.1123 -   
Control 43839 185888 705.04 20519 182643 -  
MnPhi 200 0.3134 1.3288 0.005040 0.1467 1.3056 7.148E-6 - 
 
    
Significant  
    
Not significant          
 
 
 
        
        
        
Table 3.11 Odds ratios for the first evaluation at P. aphanidermatum of fixed model.   
In this table, we can see that all treatments of seeds at the first evaluation are effective 
against P. aphanidermatum. The effect of treatments Kphi 400 and MnPhi 400 is the same and 
they seem to be the most effective treatments. The least effective treatment is Maxim 100. Also, 
if we compared this table results with the two-way factorial treatment structure results for mixed 
models of the first evaluation of seeds with P. aphanidermatum, we will see that they are in the 
same direction and have similar results. 
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For the first evaluation at P. irregulare: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.08842 -      
Maxim 100 3.0970 35.0252 -     
MnPhi 200 
+ Maxim 
0.1126 1.2731 0.03635 -    
MnPhi 400 0.009681 0.1095 0.003126 0.08600 -   
Control 169.59 1917.95 54.7592 1506.46 17517 -  
MnPhi 200 0.01513 0.1711 0.004884 0.1344 1.5624 0.000089 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.12 Odds ratios for the first evaluation at P. irregulare of fixed model.   
For seeds that infected by P. irregulare at the first evaluation, treatments are effective 
too. The highest odds ratio when comparing to control treatment is MnPhi 400 followed by 
MnPhi 200 and the lowest is Maxim 100. Moreover, the overall results are similar to what we 
found in previous sections about P. irregulare at the first evaluation.  
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For the first evaluation at P. ultimum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 1.0436 -      
Maxim 100 3.2994 3.1617 -     
MnPhi 200 
+ Maxim 
0.3484 0.3339 0.1056 -    
MnPhi 400 0.1742 0.1669 0.05279 0.4999 -   
Control 12590 12064 3815.66 36131 72279 -  
MnPhi 200 1.6706 1.6009 0.5063 4.7945 9.5913 0.000133 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.13 Odds ratios for the first evaluation at P. ultimum of fixed model.   
For P. ultimum at the first evaluation, all treatments have an effect that better than 
untreated seeds. Treatment that is the highest resistant to P. ultimum is MnPhi 400 and MnPhi 
200 + Maxim and they have the same effect. Treatments Kphi 200, Kphi 400 and MnPhi 200 
have the same effect. The minimum effect against P. ultimum is Maxim 100.  
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For the second evaluation at P. aphanidermatum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 3.2936 -      
Maxim 100 117.48 35.6706 -     
MnPhi 200 
+ Maxim 
1.7921 0.5441 0.01525 -    
MnPhi 400 0.8523 0.2588 0.007255 0.4756 -   
Control 7.0396E8 2.1374E8 5991930 3.9281E8 8.2591E8 -  
MnPhi 200 0.6522 0.1980 0.005552 0.3639 0.7652 9.27E-10 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.14 Odds ratios for the second evaluation at P. aphanidermatum of fixed model.   
We can see that three-way factorial treatment structure fixed model for seeds that 
infected by P. aphanidermatum shows that all treatments are ineffective after two weeks of being 
treated when comparing with untreated seeds (Control).  
For the second evaluation at P. irregulare: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.7358 -      
Maxim 100 1.1050 1.5016 -     
MnPhi 200 
+ Maxim 
0.7177 0.9753 0.6495 -    
MnPhi 400 1.0000 1.3590 0.9050 1.3934 -   
Control 13.3835 18.1882 12.1123 18.6487 13.3835 -  
MnPhi 200 0.4080 0.5545 0.3693 0.5685 0.4080 0.03049 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.15 Odds ratios for the second evaluation at P. irregulare of fixed model.   
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At the second evaluation for seeds infected by P. irregulare, we found that all treatments 
are still effective when comparing with untreated seeds (Control) and all of them have the same 
effects. 
For the second evaluation at P. ultimum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 3.6422 -      
Maxim 100 7.6092 2.0892 -     
MnPhi 200 
+ Maxim 
1.0347 0.2841 0.1360 -    
MnPhi 400 4.2624 1.1703 0.5602 4.1193 -   
Control 3.3762E8 92697380 44370244 3.2629E8 79209643 -  
MnPhi 200 1.7248 0.4736 0.2267 1.6669 0.4046 5.109E-9 - 
 
    
Significant  
    
Not significant           
        
        
        
        
Table 3.16 Odds ratios for the second evaluation at P. ultimum of fixed model.   
We can see that three-way logit fixed model for seeds that infected by P. ultimum shows 
that all treatments are ineffective when comparing with untreated seeds (Control) after two 
weeks of being treated which agrees with the mixed models with two-way factorial treatment 
structure results. 
 3.3.3 Two-way cumulative logit fixed model 
As we mentioned in section 3.2 that for our results of three-way cumulative logit fixed 
model to be reliable, we fitted two-way cumulative logit fixed model separately by each day and 
pathogen so that we can compare the results with the two-way mixed model for P. ultimum and 
at the first evaluation (Day 5). We also conducted pairwise comparison tests using Bonferroni 
correction and obtained the estimated odds ratios as shown in the following tables. 
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 3.3.3.1 The odds ratios on the first evaluation  
For P. aphanidermatum pathogen: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.2220 -      
Maxim 100 24.8440 111.93 -     
MnPhi 200 
+ Maxim 
2.1288 9.5908 0.08569 -    
MnPhi 400 0.2262 1.0191 0.009105 0.1063 -   
Control 4185.47 18856 168.47 1966.10 18503 -  
MnPhi 200 0.2990 1.3470 0.01203 0.1405 1.3218 0.000071 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.17 Odds ratios for P. aphanidermatum on the first evaluation of fixed model.   
For P. irregulare pathogen: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 0.1227 -      
Maxim 100 2.0844 16.9882 -     
MnPhi 200 
+ Maxim 
0.1553 1.2656 0.07450 -    
MnPhi 400 0.01265 0.1031 0.006071 0.08149 -   
Control 23.8909 194.72 11.4619 153.86 1887.95 -  
MnPhi 200 0.02020 0.1646 0.009691 0.1301 1.5963 0.000845 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.18  Odds ratios for P. irregulare on the first evaluation of fixed model.  
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For P. ultimum pathogen: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 1.0174 -      
Maxim 100 2.7229 2.6764 -     
MnPhi 200 
+ Maxim 
0.3711 0.3647 0.1363 -    
MnPhi 400 0.1853 0.1821 0.06804 0.4993 -   
Control 1276.80 1254.98 468.91 3440.84 6891.49 -  
MnPhi 200 1.5352 1.5089 0.5638 4.1371 8.2860 0.001202 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.19  Odds ratios for P. ultimum on the first evaluation of fixed model.   
When comparing theses results of fixed effect model with the results of mixed model on 
the first evaluation, we can see that the odds ratios are very similar and the significance of the 
odds ratios is the same. Overall, the results of fixed models agree with mixed effect models 
results. This implies that the petri dishes random effect may not be significant.  
 3.3.3.2 The odds ratio on P. ultimum  
Now we present the results of fitting fixed effect for P. ultimum to compare it with mixed 
effect result. 
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 For the first evaluation: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 1.0436 -      
Maxim 100 3.4922 3.3462 -     
MnPhi 200 
+ Maxim 
0.3437 0.3293 0.09841 -    
MnPhi 400 0.1838 0.1761 0.05262 0.5347 -   
Control 12992 12449 3720.28 37804 70704 -  
MnPhi 200 1.7169 1.6451 0.4916 4.9958 9.3436 0.000132 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.20 Odds ratios for the first evaluation of fixed model for P. ultimum.   
For the second evaluation: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 Control MnPhi 200 
Kphi 200 -       
Kphi 400 3.7207 -      
Maxim 100 7.7272 2.0768 -     
MnPhi 200 
+ Maxim 
1.0339 0.2779 0.1338 -    
MnPhi 400 4.3511 1.1694 0.5631 4.2086 -   
Control 2.3361E8 62786509 30232447 2.2596E8 53690554 -  
MnPhi 200 1.7424 0.4683 0.2255 1.6853 0.4004 7.458E-9 - 
 
    
Significant  
    
Not significant           
        
        
        
Table 3.21 Odds ratios for the second evaluation of fixed model for P. ultimum.   
Overall, in the first evaluation of seeds contaminated with P. ultimum, all results agree 
with what we found with mixed models that all treatments are better than the control treatment 
for the first evaluation. The odds ratio comparing Maxim 100 to Kphi 200 became significant 
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with fixed models. Treatment Kphi 200, Kphi 400, MnPhi 200 and MnPhi 200 + Maxim have 
the same effect and treatment MnPhi 400 has the highest odds ratio in comparison with untreated 
seeds. Also for the second evaluation of the same seeds, all treatments seem to be ineffective 
when comparing to untreated seeds. Clearly the time factor has an effect on the treatments 
resistance to the isolates in the second evaluation. 
 3.3.4 Excluding Control Treatment   
As we saw in figure 1.4, Control treatment (untreated seeds) does not have much 
variability. Most of seeds tend to be non-germinating which results in high frequency at category 
4 and 5 and zeros frequencies in the remaining categories of the response variable making more 
noise in the data. Therefore, we excluded the Control treatment from the data and fitted 3-way 
logit mixed model and again we couldn’t estimate the random effect of petri dish. Then we fitted 
3-way logit fixed model and we obtained the following results.  
For the first evaluation at P. aphanidermatum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 0.06412 -     
Maxim 100 10.9627 43.1094 -    
MnPhi 200 
+ Maxim 
0.6508 2.4797 0.005930 -   
MnPhi 400 0.06900 0.2837 0.000623 0.03119 -  
MnPhi 200 0.08977 0.3648 0.000814 0.04068 0.3787 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.22 Odds ratios for the first evaluation at P. aphanidermatum of fixed model 
excluding the Control treatment.   
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When comparing with results of the data including the Control treatment, the significance 
of the odds ratios hasn’t changed but now the values of the odds ratios seem to be lower.   
For the first evaluation at P. irregulare: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 0.08724 -     
Maxim 100 3.1037 35.5755 -    
MnPhi 200 
+ Maxim 
0.1112 1.2748 0.03583 -   
MnPhi 400 0.009357 0.1073 0.003015 0.08413 -  
MnPhi 200 0.01470 0.1685 0.004735 0.1321 1.5706 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.23 Odds ratios for the first evaluation at P. irregulare of fixed model excluding the 
Control treatment.   
For P. irregulare at the first evaluation, the results are very similar with and without the 
control treatment. 
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For the first evaluation at P. ultimum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 1.0429 -     
Maxim 100 3.3183 3.1819 -    
MnPhi 200 
+ Maxim 
0.3465 0.3323 0.1044 -   
MnPhi 400 0.1724 0.1654 0.05197 0.4977 -  
MnPhi 200 1.6748 1.6060 0.5047 4.8335 9.7122 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.24 Odds ratios for the first evaluation at P. ultimum of fixed model excluding the 
Control treatment.   
For P. ultimum at the first evaluation, the results are very similar with and without the 
control treatment. 
For the second evaluation at P. aphanidermatum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 3.2998 -     
Maxim 100 113.54 34.4091 -    
MnPhi 200 
+ Maxim 
1.7939 0.5437 0.01580 -   
MnPhi 400 0.8519 0.2582 0.007502 0.4749 -  
MnPhi 200 0.6509 0.1973 0.005733 0.3628 0.7641 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.25 Odds ratios for the second evaluation at P. aphanidermatum of fixed model 
excluding the Control treatment.   
For the second evaluation at P. aphanidermatum, the results are very similar with and 
without the control treatment. 
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For the second evaluation at P. irregulare: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 0.7361 -     
Maxim 100 1.1028 1.4982 -    
MnPhi 200 
+ Maxim 
0.7180 0.9754 0.6510 -   
MnPhi 400 1.0000 1.3585 0.9068 1.3928 -  
MnPhi 200 0.4080 0.5542 0.3700 0.5682 0.4080 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.26 Odds ratios for the second evaluation at P. irregulare of fixed model excluding 
the Control treatment.   
We can see that after excluding the Control treatment the results are almost the same. 
For the second evaluation at P. ultimum: 
 Kphi 200 Kphi 400 Maxim 100 
MnPhi 200 
+ Maxim 
MnPhi 400 MnPhi 200 
Kphi 200 -      
Kphi 400 3.6421 -     
Maxim 100 7.5579 2.0751 -    
MnPhi 200 
+ Maxim 
1.0344 0.2840 0.1369 -   
MnPhi 400 4.2558 1.1685 0.5631 4.1141 -  
MnPhi 200 1.7258 0.4738 0.2283 1.6683 0.4055 - 
 
    
Significant  
    
Not significant          
        
        
       
Table 3.27 Odds ratios for the second evaluation at P. ultimum of fixed model excluding the 
Control treatment.   
We can see that after excluding the Control treatment the results are almost the same. 
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 3.3.5 Collapsing over Categories of the Response Variable   
As we mentioned in section 3.2, we collapsed the categories of the response variable to 
get larger frequencies. Instead of having six categories, we tried three categories and two 
categories of the response variable. For three categories, we collapsed categories 1, 2, and 3 as 
one category and 4 and 5 as another category so that overall, we have 0, 1 and 2 categories of the 
response variable where 0 = “germinated seeds”, 1 = “less germination”, and 2 = “almost non-
germinated seeds”. Then, we fitted proportional logit model with mixed effect as a three-way 
factorial treatment structure in GLIMMIX procedure in SAS using Laplace approximation. 
Unfortunately, we encountered the same problem that we could not estimate the petri dish effect. 
Next, we fitted proportional logit model with fixed effect as a three-way factorial treatment 
structure in GLIMMIX procedure in SAS and the Type III ANOVA table degrees of freedom 
were estimated incorrectly. Finally, we tried a binary response variable. We collapsed categories 
0, 1, 2, and 3 as one category and 4 and 5 as another category so that overall, we have only two 
outcomes, 0 = “germinated or partly germinated seeds”, and 1 = “almost non-germinated seeds”.  
We fitted proportional logit model with mixed effect as a three-way factorial treatment structure 
in GLIMMIX procedure in SAS using Laplace approximation. Even though SAS did estimate 
the petri dish random effect, it gives Type III ANOVA table with wrong degrees of freedom. 
Additionally, we also fitted proportional logit model with fixed effect as a three-way factorial 
treatment structure in GLIMMIX procedure in SAS but we obtained the wrong Type III ANOVA 
table degrees of freedom. 
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Chapter 4 - Power Analysis 
In this chapter, we explain and present the results of the power analysis we conducted to 
evaluate the impact of our sample sizes in multinomial experiments similar to our case study. We 
used a modified version of the three steps procedure suggested by Stroup, 2013 to calculate 
GLMMs’ power. The procedure consists of first, create an artificial dataset whose estimates 
would match the conditional expectations, i.e., probabilities, we expect to see and/or test. Then, 
fit a GLM or GLMM using GLIMMIX procedure in SAS®; and finally, use GLIMMIX’s results 
to calculate the power. In the next section, we explain the procedure in detail and present our 
results. 
 4.1 Power Calculations  
 When Drs. Carmona and Perez-Hernandez designed their experiment, their main 
objective was to evaluate the effectiveness of several products to hinder the negative effect of 
pathogen infection on soybean seeds. Although they did not conduct a power analysis for 
determination of sample size in their experiment, they followed the “usual” design and sample 
size in their field. Conducting a power analysis should be encouraged in any circumstance, the 
rationality behind is beyond the scope of this project so we will focus our attention on our 
findings. For a detailed discussion on the importance of this step refer to Chapter 16, Stroup, 
2013.  
The following power calculations are not valid in the sense that they were done after the 
experiment. However, we were very curious about the consequences of the sample size 
selections on our results and lack of fit in the case of the random effect. Stroup 2013 suggests a 
three steps procedure to conduct a power analysis for a GLMM. Step one construct a data set 
with the same number of observations per block/treatment combination as the proposal 
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experiment structure and sample size, and use E(Y|b), i.e. the expected data mean given the 
random effects, as your observed values. The chosen means should reflect the differences that we 
want to evaluate. For instance, in a binomial model we may assume the control probability of 
success in 0.20 and want to compute the power of detecting an increment of 0.10. Therefore, we 
will create an exemplary data set with 20% of ones (successes) in our control group and 30% of 
ones in treatment one. Step two consists of fitting the model with SAS® PROG GLIMMIX 
including estimation of all the comparisons of interest, such as pairwise contrast: 𝜏𝑖 − 𝜏𝑖′ , 𝑖 ≠ 𝑖′, 
keeping the covariance components constant, i.e. SAS should not estimate the variance 
parameter(s). We must set them according to our knowledge about the process. For each 
estimable function of interest, GLIMMIX computes approximate F-statistic. Step three use the 
estimated F values and degrees of freedom to obtain the critical value and the non-centrality 
parameter under the proposed design, best-guess covariance components and expected/important 
treatment effect. Then, the power to detect each comparison of interest is calculated as the area to 
the right of the critical value under the noncentral F.  
For creating our exemplary datasets given our conclusion about factor interactions from 
chapter 3, we removed the Pathogen and Day factors and assumed that the results would be 
equivalent to fit each Pathogen*Day combination separately. Thus, we defined seven treatments 
with different theoretical or expected probabilities of observing each of the six categories (0-5). 
The probabilities are listed in Table 4.1. Watchful of technical and logistical limitations, we tried 
only three designs: 10 petri dishes, 5 seeds per dish (like our case study); 10 petri dishes, 10 
seeds per dish; and 20 petri dishes, 5 seeds per dish. At this point, we had to deviate from Stroup, 
2013 because E(Y|b) resulted fractional, i.e. we only had 5 or 10 seeds to divide into six 
categories. Instead of creating one exemplary data, we generate 1,000 sets drawing the observed 
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counts from a multinomial with N= number of seeds per dish, and probabilities π0, π1, π2, …., 
π5 according to Table 4.1. 
Power Calculations 
 Theoretical Probabilities per Category 
Treatment 0 1 2 3 4 5 
Control 0 0 0 0 0.05 0.95 
Exp  1 0.3 0.5 0.2 0 0 0 
Exp  2 0.1 0.3 0.1 0.1 0.1 0.3 
Exp  3 0.15 0.8 0.05 0 0 0 
Exp  4 0.05 0.45 0.45 0.05 0 0 
Exp  5 0 0 0 0.1 0.75 0.15 
Exp  6 0 0 0.1 0.75 0.15 0 
Table 4.1 Theoretical probabilities for the power analysis for multinomial responses.   
For step two, we fitted a fixed effects model (assuming the dish effect is zero) and two 
mixed effects models one setting 𝜎𝐷
2=0.1 and another with 𝜎𝐷
2=0.01, where 𝜎𝐷
2 represents the dish 
effect variance from equation 3.2. In all cases we used the same significance level from the case 
study, set to 0.238% for Bonferroni’s adjustment for multiple comparisons. In the next section, 
we present our findings. The SAS code used for the simulation and the power calculations is 
included in Appendix C. 
 4.2 Power Results  
In table 4.2, we present the average estimated power to detect a difference between two 
hypothetical expected means.  As evident from the obtained results, we have good power to 
detect most of the potential difference with the exception of some comparisons with 
experimental treatment 2 and one extreme case, experiment 1 vs. 3. This treatment comparison 
scored almost no power (equal to significance level) to be detected, when in reality their 
probabilities are not very close.  
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 10 Petri Dishes, 
5 Seeds per dish 
10 Petri Dishes, 
10 Seeds per dish 
20 Petri Dishes, 
5 Seeds per dish 
Contrast Fixed 
Mixed 
Fixed 
Mixed 
Fixed 
Mixed 
𝜎𝐷
2=0.1 𝜎𝐷
2=0.01 𝜎𝐷
2=0.1 𝜎𝐷
2=0.01 𝜎𝐷
2=0.1 𝜎𝐷
2=0.01 
Ctrl vs. Exp 1 0.912 0.912 0.912 0.993 0.993 0.993 0.990 0.990 0.990 
Ctrl vs. Exp 2 0.908 0.906 0.906 0.993 0.993 0.993 0.990 0.990 0.990 
Ctrl vs. Exp 3 0.912 0.912 0.912 0.993 0.993 0.993 0.990 0.990 0.990 
Ctrl vs. Exp 4 0.912 0.912 0.912 0.993 0.993 0.993 0.990 0.990 0.990 
Ctrl vs. Exp 5 0.898 0.893 0.892 0.993 0.992 0.992 0.990 0.990 0.990 
Ctrl vs. Exp 6 0.912 0.912 0.912 0.993 0.993 0.993 0.990 0.990 0.990 
Exp 1 vs. Exp 2 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 1 vs. Exp 3 0.027 0.025 0.022 0.030 0.027 0.021 0.029 0.028 0.024 
Exp 1 vs. Exp 4 0.763 0.733 0.694 0.974 0.964 0.933 0.974 0.970 0.959 
Exp 1 vs. Exp 5 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 1 vs. Exp 6 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 2 vs. Exp 3 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 2 vs. Exp 4 0.998 0.998 0.997 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 2 vs. Exp 5 0.284 0.267 0.255 0.472 0.443 0.397 0.483 0.471 0.456 
Exp 2 vs. Exp 6 0.510 0.486 0.454 0.764 0.736 0.675 0.770 0.758 0.727 
Exp 3 vs. Exp 4 0.772 0.738 0.691 0.982 0.972 0.938 0.983 0.980 0.968 
Exp 3 vs. Exp 5 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 3 vs. Exp 6 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 4 vs. Exp 5 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 4 vs. Exp 6 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 
Exp 5 vs. Exp 6 0.989 0.984 0.973 1.000 1.000 1.000 1.000 1.000 1.000 
Table 4.2 Simulation average power for comparisons between treatments of different 
sample sizes and different models, “Ctrl” and “Exp” refer to control and experimental 
treatment, respectively.   
The average may not reflect the variability of the power obtained in each of the 1000 
simulations. Figures 4.1, 4.2 and 4.3 display the distribution of the estimated power by 
simulation for some comparisons to illustrate three situations that can happen. The rest of the 
plots are included in Appendix A. Figure 4.1 shows that comparing control against the 
experiments, experiment 1 in this case, will give a power of one even with the smallest sample 
size. However, sometimes we get a small value that is associated with simulating an exemplary 
data that produces a false negative. Figure 4.2 shows experiment 2 against 6, for this case the 
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power is low in general, but may be fixed by increasing the sample size. Lastly, figure 4.3 is the 
extreme case of experiment 1 against 3, whose power starts very low (significance level) and 
does not improve regardless the sample size increments. 
 
Figure 4.1 Power to detect a difference between Control and Experiment 1 (defined in 
Table 4.1). Simulation average power is marked (dotted line). Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure 4.2 Power to detect a difference between Experiments 2 and 6 (defined in Table 4.1). 
Simulation average power is marked (dotted line). Three combinations of petri dish and 
seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure 4.3 Power to detect a difference between Experiments 1 and 3 (defined in Table 4.1). 
Simulation average power is marked (dotted line). Three combinations of petri dish and 
seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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So far, we have found evidence that the sample size is enough to detect large shifts in the 
probabilities per category, but will not be able to detect subtle differences. We can also conclude 
that across all simulation results we did not detect a significant gain or loss from including the 
variance component. In other words, we found that making the petri dish a random effect would 
not change the power results. 
One open question left for future research is how many observations are needed to 
estimate 𝜎𝐷
2 properly. We left it for future work together with alternative methods to modeling 
the data such as Bayesian or Bootstrap approaches. 
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Chapter 5 - Conclusion 
On this report, we illustrated the statistical approach to analyze ordered categorical data 
with low frequencies using real data. Our case study originated in an experimental design set up; 
therefore, we focused on generalized linear mixed models, more specifically in the cumulative 
logit or proportional odds mixed model. Laplace approximation was the recommended technique 
in the literature for our case study. This is not the default estimation technique in PROC 
GLIMMIX. Users of the software should be aware that they must evaluate which estimation 
technique works best for their case before running any analysis.   
During the modeling process explained in detail in chapter 3, we encountered two 
recurrent problems. The first one involved the estimation of the covariance parameters. 
Whenever we tried to estimate some types of random effect, repeated measurement or random 
petri dish effect, we frequently faced lack of convergence or singular variance-covariance matrix. 
Given the magnitude of the estimated random petri dish effect on the few occasions that it was 
obtained, it is likely that its true value is close to zero. We believe that the lack of estimation was 
caused in part by this fact. The small sample size contribution to the problem might have been 
partial, but most likely it made the estimation in the boundary of the parameter’s space harder.    
The second of our recurrent problems was the incorrect calculation of degrees of freedom 
on the ANOVA tables. This one is perhaps the most concerning from the practitioner’s point of 
view. The miscalculation happened regardless of model complexity, with or without random 
effects, and even for the binomial case logistic regression. Sometimes it was easy to detect 
because it came with p-values equal to 1, others it was hidden in plain sight. It is likely a 
computational problem rather than a statistical one. However, it made the rest of the results 
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produced GLIMMIX unusable, not knowing how far the consequences of the error causing the 
degrees of freedom miscalculation go.   
In spite of the fact that we could not estimate the parameters of the statistically correct 
model or test if the petri dish random effect has a significant effect formally, we believe our 
findings are sound and we could answer the scientific question about the potential effects of 
commercial products in the control of the pathogen induced disease being studied, when 
evaluated at a six categories severity scale. The main conclusion of the case study being analyzed 
is that regardless of the model, GLM or GLMM, the data always produced the same results with 
regards of the treatment effects. Furthermore, excluding the Control treatment did not affect the 
obtained results or improved the estimation. There is a significant interaction between Treatment, 
Pathogen and Day factors. Thus, treatment comparisons should be made for each Pathogen*Day 
combination separately. All types of effect models (fixed or mixed) agree that for soybean seeds 
inoculated with P. aphanidermatum, the treatments that offer the most potential to reduce the 
disease’s severity on the first evaluation are MnPhi 400 and Kphi 400 when comparing to 
untreated seeds. They have the same efficacy as MnPhi 200 and Kphi 400 while the least 
resistance is provided by Maxim 100. Moreover, for seeds inoculated with P. irregulare on the 
first evaluation the most protection was shown by MnPhi 400, followed by Kphi 400 while the 
lowest protection was displayed by Maxim 100. In addition, for seeds contaminated with P. 
ultimum at the first evaluation, the best product resulted to be MnPhi 400 and MnPhi 200 + 
Maxim both having similar effects, while the least effective product is Maxim 100. On the other 
hand, after two weeks with P. ultimum and P. aphanidermatum, all treatments seem to be 
ineffective which implies that the six treatments age against P. ultimum and P. aphanidermatum 
in less than two weeks. For P. irregulare, all treatments offer some protection against damping-
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off and work with the same efficacy. We also found that overall MnPhi 400 seems to be the best 
product against all three pathogens while Maxim 100 is the least effective. All products efficacy 
is less than two weeks for P. ultimum and P. aphanidermatum while all of them offer some 
resistance after two weeks when comparing to Control treatment with P. irregulare but there is 
no difference between treatments  
Five seeds might not be enough with a multinomial data with six categories to estimate a 
random effect from the petri dish. We try collapsing categories, but GLIMMIX produced strange 
and unexpected degrees of freedom for this data set. Although it seems that we are gaining 
information by reducing the number of possible outcomes, the cumulative logit model we used 
only estimates one additional parameter per category, the intercepts in equation 2.2. We 
conducted a power analysis to study the effects of sample sizes and designs similar to our case 
study, where technical limitations and finite resources make it impossible to observe a very large 
sample. 
The power analysis detailed in chapter 4 used a modified version of the three process 
suggested by Stroup 2013. We tested three sample sizes 10 petri dishes, 5 seeds per dish; 10 petri 
dishes, 10 seeds per dish; and 20 petri dishes, 5 seeds per dish. We kept the 6 category levels for 
the response variable and the seven treatments. Given our conclusion about factor interactions 
from chapter 3, we removed the Pathogen and Day factors and assumed that the results would be 
equivalent to fit each Pathogen*Day combination separately. Data was simulated accordingly 
some hypothetical differences between categories and treatment effects listed in table 4.1. 
Results are presented in table 4.2 and graphically in both chapter 4 and appendix A. Accordingly 
with our power analysis, we can conclude that 10 petri dishes, 5 seeds per dish seem to be 
enough observations to detect large shifts in the frequencies per category, but not to identify 
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moderate movements.  Regarding the impact of these findings on our case study’s conclusions, it 
is important to point out that although we found that most products did effectively slow the 
pathogen infection, the sample size is potentially too small to detect more subtle differences. 
Thus, products that look equally effective in this experiment may be indeed much more different 
in their potential to control Pythium damping-off in soybean. The results of this study suggest 
that similar experiments to the one herein described would need to increase the sample size or 
modify the experiment structure to be able to detect treatment effects, thereby measure the 
potential effect of the petri dish. 
The results of the study encourage testing of alternative approaches to modeling the low 
frequency data, for example, Bayesian Hierarchical Models or a Bootstrap approach, which 
could lead to more sound conclusions. Another aspect to consider in this situation is the 
exploration of how many observations are needed to estimate 𝜎𝐷
2 properly and whether or not the 
physical limitations would make the task impractical. 
 
 
 
 
  
53 
References  
 
Agresti, A. (2007). An introduction to categorical data analysis. Hoboken, NJ: Wiley-
Interscience.  
 
Agresti, A. (2013). Categorical Data Analysis. Hoboken, NJ: John Wiley & Sons, 
Incorporated. 
 
Broders KD, Lipps PE, Paul PA and Dorrance AE, Characterization of Pythium spp. 
associated with corn and soybean seed and seedling disease in Ohio. Plant Dis 91:727-735 
(2007). 
 
Carmona, M. A., Sautua, F. J., Grijalba, P. E., Cassina, M., & Pérez-Hernández, O. 
(2017). Effect of potassium and manganese phosphites in the control of Pythium damping-off in 
soybean: a feasible alternative to pathogenscide seed treatments. Pest Management Science. 
doi:10.1002/ps.4714. 
 
Jiang, J. (2007). Linear and generalized linear mixed models and their applications. New 
York: Springer. 
 
Jiang YN, Haudenshield JS, and Hartman GL, Characterization of Pythium spp. from soil 
samples in Illinois. Can J Plant Pathol 34:448-454 (2012). 
 
Kirkpatrick MT, Rupe JC and Rothrock CS, Soybean response to flooded soil conditions 
and the association with soilborne plant pathogenic genera. Plant Dis 90:592-596 (2006). 
 
Milliken, G. A., & Johnson, D. E. (2009). Analysis of messy data: volume 1 - designed 
experiments. New York: Chapman & Hall. 
 
National Health and Nutrition Examination Survey (2016). 2013-2014 Data 
documentation, codebook, and frequencies: depression screener. Retrieved October 11, 2017, 
from https://wwwn.cdc.gov/Nchs/Nhanes/2013-2014/DPQ_H.htm 
SAS Institute Inc. 2008. SAS/STAT® 9.2 User’s Guide. Cary, NC: SAS Institute Inc.  
 
Snell, E. J.(1964). A Scaling Procedure for Ordered Categorical Data. Biometrics, 20(3), 
592-607. 
 
Stroup, W. W. (2013). Generalized linear mixed models. modern concepts, methods and 
applications. Boca Raton, FL: CRC Press. 
54 
 
Wicklin, R. (2016) SAS Blogs The DO Loop. Simulate from the multinomial distribution 
in the SAS DATA step, March 16, 2016. Retrieved October 12, 2017, from 
https://blogs.sas.com/content/iml/2016/03/16/simulate-multinomial-sas-data-step.html 
 
  
55 
Appendix A - Power Analysis Plots 
The figures present here display the estimated power to detect the difference between two 
hypothetical expected means. We plot the computed power for each of the 1000 simulated data 
sets for three combinations of petri dish and seeds per dish sample sizes, and using either a fixed 
model or a mixed model with variance 0.01, or 0.1. The fixed model assumed the petri dish 
effect was zero. The mixed model assumed the petri dish effect was random and followed a 
Gaussian distribution with variance 0.01 or 0.1. The simulation and computational details are 
presented in Chapter 4. The SAS code used for the simulation can be found in Appendix C. 
 
Figure A.1 Power to detect a difference between Control and Experiment 1 (defined in 
Table 4.1). Simulation average power is marked (dotted line). Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.2 Power to detect a difference between Control and Experiment 2 (defined in 
Table 4.1). Simulation average power is marked (dotted line). Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.3 Power to detect a difference between Control and Experiment 3 (defined in 
Table 4.1). Simulation average power is marked (dotted line).  Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.4 Power to detect a difference between Control and Experiment 4 (defined in 
Table 4.1). Simulation average power is marked (dotted line).  Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.5 Power to detect a difference between Control and Experiment 5 (defined in 
Table 4.1). Simulation average power is marked (dotted line).  Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.6 Power to detect a difference between Control and Experiment 6 (defined in 
Table 4.1). Simulation average power is marked (dotted line). Three combinations of petri 
dish and seeds per dish sample sizes (columns) were simulated a thousand times. Power 
was calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.7 Power to detect a difference between Experiments 1 and 2 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.8 Power to detect a difference between Experiments 1 and 3 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.9 Power to detect a difference between Experiments 1 and 4 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
60 
 
Figure A.10 Power to detect a difference between Experiments 1 and 5 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.11 Power to detect a difference between Experiments 1 and 6 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.12 Power to detect a difference between Experiments 2 and 3 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.13 Power to detect a difference between Experiments 2 and 4 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.14 Power to detect a difference between Experiments 2 and 5 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.15 Power to detect a difference between Experiments 2 and 6 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.16 Power to detect a difference between Experiments 3 and 4 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.17 Power to detect a difference between Experiments 3 and 5 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.18 Power to detect a difference between Experiments 3 and 6 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.19 Power to detect a difference between Experiments 4 and 5 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Figure A.20 Power to detect a difference between Experiments 4 and 6 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
 
Figure A.21 Power to detect a difference between Experiments 5 and 6 (defined in Table 
4.1). Simulation average power is marked (dotted line). Three combinations of petri dish 
and seeds per dish sample sizes (columns) were simulated a thousand times. Power was 
calculated under fixed model or a mixed model with variances 0.01 or 0.1 (rows). 
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Appendix B - SAS Code Data Analysis 
/* We refer to the Control treatment here as Testigo*/  
/* EXP and Odds ratio options give the same results in Estimate statement */ 
PROC TABULATE DATA=allpredictors; 
CLASS treatment Day Fungus Dish Severity; 
TABLE  Fungus*Treatment*Dish ,Day*Severity; 
RUN; 
proc glimmix data=allpredictors method = laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ; 
random Dish(Treatment Fungus); 
run; 
proc sort data=allpredictors out=allpredictorsDay; by day; run;    
title 'Interaction Effects Mixed Model by Day'; 
proc glimmix data=allpredictorsDay method=Laplace; 
by Day; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Fungus Treatment*Fungus / solution oddsratio; 
random intercept / subject=dish(treatment Fungus); 
run; 
data Day5; 
set allpredictors; 
if Day=5; 
run; 
proc sort data=day5; by Fungus;run; 
data Day21; 
set allpredictors; 
if Day=21; 
run; 
proc sort data=day21; by Fungus;run; 
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proc glimmix data=Day5 method=Laplace; 
by Fungus; 
class treatment Severity Fungus Dish; 
model Severity=Treatment / solution oddsratio; 
random intercept / subject=dish(treatment); 
run; 
title 'Interaction Effects Mixed Model Day21 by Fungus'; 
proc glimmix data=Day21 method=Laplace; 
by Fungus; 
class treatment Severity Fungus Dish; 
model Severity=Treatment / solution oddsratio; 
random intercept / subject=dish(treatment); 
run;    
proc sort data=allpredictors out=allpredictorsFUNGUS; by Fungus; run; 
proc glimmix data=allpredictorsFungus method=Laplace; 
by Fungus; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Day Treatment*Day / solution oddsratio; 
random intercept / subject=dish(treatment); 
run;    
data Apha; 
set allpredictors; 
if Fungus='Apha'; 
run; 
proc sort data=Apha; by day; run; 
data Ultimun; 
set allpredictors; 
if Fungus='U'; 
run; 
proc sort data=Ultimun; by day; run; 
data Irregulare; 
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set allpredictors; 
if Fungus='I'; 
run; 
proc sort data=Irregulare; by day; run; 
proc glimmix data=Apha method=Laplace; 
by Day; 
class treatment Severity Fungus Dish; 
model Severity=Treatment / solution oddsratio; 
random intercept / subject=dish(treatment); 
run; 
proc glimmix data=Ultimun method=Laplace; 
by Day; 
class treatment Severity Fungus Dish; 
model Severity=Treatment / solution oddsratio; 
random intercept / subject=dish(treatment); 
run; 
proc glimmix data=Irregulare method=Laplace; 
by Day; 
class treatment Severity Fungus Dish; 
model Severity=Treatment / solution oddsratio; 
random intercept / subject=dish(treatment); 
run; 
data allNoTestigo; 
set allpredictors; 
if treatment="Testigo" then delete; 
run; 
proc glimmix data=allNoTestigo method = laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ; 
random Dish(Treatment Fungus); 
run; 
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data MnPhi200ToZMnPhi200; 
set allpredictors; 
if treatment="MnPhi 200" then treatment="ZMnPhi 200"; 
run; 
proc sort data=MnPhi200ToZMnPhi200 out=allpredictorsDay; by day; run; 
proc glimmix data=allpredictorsDay method=Laplace; 
by Day; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Fungus Treatment*Fungus / solution oddsratio ; 
random intercept / subject=dish(treatment Fungus); 
ESTIMATE 'Kphi 200  vs. Kphi 400 at Aphanidermatum'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Aphanidermatum'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Testigo at Aphanidermatum'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Aphanidermatum'  Treatment 1 0 0 0 0 0 -1 
                                Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Aphanidermatum'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
71 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 1 0 0 -
1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;   
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at at Irregular'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Testigo at Irregular'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular'  Treatment 1 0 0 0 0 0 -1 
                                Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0  /oddsratio 
alpha=0.00238 cl;  
72 
ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Irregular'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Irregular'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular'  Treatment 0 0 0 1 0 -1 0 
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                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Irregular'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs. Kphi 400 at Ultimun'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Testigo at Ultimun'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun'  Treatment 1 0 0 0 0 0 -1 
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                                Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Ultimun'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Ultimun'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun'  Treatment 0 0 0 1 -1 0 0 
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                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1  
/oddsratio alpha=0.00238 cl;  
run; 
proc sort data=MnPhi200ToZMnPhi200 out=allpredictorsFUNGUS; by Fungus; run;    
proc glimmix data=allpredictorsFungus method=Laplace; 
by Fungus; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Day Treatment*Day / solution oddsratio; 
random intercept / subject=dish(treatment); 
ESTIMATE 'Kphi 200  vs. Kphi 400 at Day5'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Day 1 0 -1 0 0 0 0 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Day5'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Day 1 0 0 0 -1 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Day5'  Treatment 1 0 0 -1 0 0 0 
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                                 Treatment*Day 1 0 0 0 0 0 -1 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Day5'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Testigo at Day5'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Day5'  Treatment 1 0 0 0 0 0 -1 
                                Treatment*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Day5'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Day 0 0 1 0 -1 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Day5'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Day 0 0 1 0 0 0 -1 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Day5'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Day 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs Testigo at Day5'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Day5'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Day 0 0 1 0 0 0 0 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Day5'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Day 0 0 0 0 1 0 -1 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Day5'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 1 0 0 0 -1 0 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
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ESTIMATE 'Maxim 100  vs Testigo at Day5'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Day5'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Day5'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Day5'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Day5'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 1 0 -1 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs. Kphi 400 at Day21'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Day 0 1 0 -1 0 0 0 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Day21'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Day 0 1 0 0 0 -1 0 0 0 0 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Day21'  Treatment 1 0 0 -1 0 0 0 
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                                 Treatment*Day 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Day21'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Testigo at Day21'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Day21'  Treatment 1 0 0 0 0 0 -1 
                                Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Day21'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Day 0 0 0 1 0 -1 0 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Day21'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Day 0 0 0 1 0 0 0 -1 0 0 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Day21'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 -1 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Day21'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Day21'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Day21'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Day 0 0 0 0 0 1 0 -1 0 0 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Day21'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
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ESTIMATE 'Maxim 100  vs Testigo at Day21'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Day21'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Day21'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Day21'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Day21'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 -1 /oddsratio alpha=0.00238 
cl;  
run; 
proc sort data=MnPhi200ToZMnPhi200 out=allpredictorsDay; by day; run; 
title 'Fixed effect model BY DAY'; 
proc glimmix data=allpredictorsDay method=Laplace; 
by Day; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Fungus Treatment*Fungus / solution oddsratio;       
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ESTIMATE 'Kphi 200  vs. Kphi 400 at Aphanidermatum'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Aphanidermatum'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Testigo at Aphanidermatum'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Aphanidermatum'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Aphanidermatum'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 1 0 0 0 0 -1 
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                                 Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 1 0 0 -
1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum'  Treatment 0 0 0 0 1 -1 0  
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 0 1 0 -1  
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum'  Treatment 0 0 0 0 0 1 -1  
82 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular'  Treatment 1 -1 0 0 0 0 0  
                                 Treatment*Fungus 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular'  Treatment 1 0 -1 0 0 0 0  
                                 Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Irregular'  Treatment 1 0 0 -1 0 0 0  
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular'  Treatment 1 0 0 0 -1 0 0  
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Irregular'  Treatment 1 0 0 0 0 -1 0  
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Irregular'  Treatment 0 1 0 0 0 -1 0 
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                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Irregular'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Irregular'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 0 1 0 -1 
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                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Kphi 400 at Ultimun'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Ultimun'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun'  Treatment 0 1 0 0 -1 0 0 
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                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Ultimun'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Ultimun'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun'  Treatment 0 0 0 0 1 -1 0 
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                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1  
/oddsratio alpha=0.00238 cl; 
run; 
 
proc sort data=MnPhi200ToZMnPhi200 out=allpredictorsFUNGUS; by Fungus; run; 
proc glimmix data=allpredictorsFungus method=Laplace; 
by Fungus; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment Day Treatment*Day / solution oddsratio; 
ESTIMATE 'Kphi 200  vs. Kphi 400 at Day5'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Day 1 0 -1 0 0 0 0 0 0 0 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Day5'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Day 1 0 0 0 -1 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Day5'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Day 1 0 0 0 0 0 -1 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Day5'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Testigo at Day5'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Day5'  Treatment 1 0 0 0 0 0 -1 
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                                Treatment*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Day5'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Day 0 0 1 0 -1 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Day5'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Day 0 0 1 0 0 0 -1 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Day5'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Day 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs Testigo at Day5'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Day5'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Day 0 0 1 0 0 0 0 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Day5'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Day 0 0 0 0 1 0 -1 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Day5'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 1 0 0 0 -1 0 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Day5'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Day5'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Day5'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 -1 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
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ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Day5'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Day5'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 0 0 -1 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Day5'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 1 0 -1 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs. Kphi 400 at Day21'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Day 0 1 0 -1 0 0 0 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Day21'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Day 0 1 0 0 0 -1 0 0 0 0 0 0 0 0  /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Day21'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 -1 0 0 0 0 0 0/oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Day21'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs Testigo at Day21'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Day21'  Treatment 1 0 0 0 0 0 -1 
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                                    Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Maxim 100 at Day21'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Day 0 0 0 1 0 -1 0 0 0 0 0 0 0 0 /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Day21'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Day 0 0 0 1 0 0 0 -1 0 0 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Day21'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 -1 0 0 0 0   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Day21'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Day21'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Day21'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Day 0 0 0 0 0 1 0 -1 0 0 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Day21'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs Testigo at Day21'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Day21'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Day21'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 -1 0 0 0 0  /oddsratio alpha=0.00238 
cl;  
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ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Day21'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1   /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Day21'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1 0 0  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 -1  /oddsratio alpha=0.00238 
cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Day21'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 -1 /oddsratio alpha=0.00238 
cl;  
run; 
 
proc glimmix data=MnPhi200ToZMnPhi200 method = laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ;      
ESTIMATE 'Kphi 200  vs Kphi 400 at Aphanidermatum at Day 5'  Treatment 1 -1 0 0 0 0 0 
                                    Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 1 0 -1 0 0 0 0 0 0 0 0 0 0 0 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Max 100 at Aphanidermatum at Day 5'  Treatment 1 0 -1 0 0 0 0 
                                    Treatment*Fungus 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 1 0 0 0 -1 0 0 0 0 0 0 0 0 0 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'  Treatment 1 0 0 -
1  
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                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 1 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum at Day 5'  Treatment 1 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 1 0 0 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
-1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs at Testigo at Day 5'  Treatment 1 0 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs at ZMnPhi 200 at Day 5'  Treatment 1 0 0 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Max 100 at Aphanidermatum at Day 5'  Treatment 0 1 -1 0 0 0 0 
                                    Treatment*Fungus 0 0 0 1 0 0 -1  
                                    Treatment*Day 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'  Treatment 0 1 0 -
1 0 0 0 
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 1 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum at Day 5'  Treatment 0 1 0 0 -1 0 0 
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                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 1 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
-1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum at Day 5'  Treatment 0 1 0 0 0 -1 0 
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum at Day 5'  Treatment 0 1 0 0 0 0 -1  
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 1 0 0 0 0 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'  Treatment 0 0 1 
-1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 1 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum at Day 5'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 0 0 1 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
-1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum at Day 5'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum at Day 5'  Treatment 0 0 1 0 0 0 -1 
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                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum at Day 5'  Treatment 0 0 0 
1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
-1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum at Day 5'  Treatment 0 0 0 1 0 
-1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum at Day 5'  Treatment 0 0 
0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0   
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum at Day 5'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum at Day 5'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 0 0 -1    
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum at Day 5'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0    
                                    Treatment*Day 0 0 0 0 0 0 0 0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular at Day 5'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 -1  
                                 Treatment*Day 1 0 -1    
                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular at Day 5'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at at Irregular at Day 5'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 
                                 Treatment*Day 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular at Day 5'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
                                 Treatment*Day 1 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Irregular at Day 5'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1    
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                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0   
                                    Treatment*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular at Day 5'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular at Day 5'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular at Day 5'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Day 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Irregular at Day 5'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 1 0 0 0 0 0 0 0 0 0 -1     
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular at Day 5'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0    
                                 Treatment*Day 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular at Day 5'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0    
                                 Treatment*Day 0 0 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Irregular at Day 5'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0   
                                 Treatment*Day 0 0 0 0 1 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular at Day 5'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular at Day 5'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0  
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1     
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 0 0 0 1 0 0 -
1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Irregular at Day 5'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular at Day 5'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0    
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs. Kphi 400 at Ultimun at Day5'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                 Treatment*Day 1 0 -1     
                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 
cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun at Day5'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 1 0 0 0 -1     
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                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun at Day5'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun at Day5'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
                                 Treatment*Day 1 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Ultimun at Day5'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 
                                 Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun at Day5'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0   
                                 Treatment*Day  0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun at Day5'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day  0 0 1 0 0 0 -1    
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun at Day5'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
                                    Treatment*Day  0 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Ultimun at Day5'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
                                    Treatment*Day  0 0 1 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                 Treatment*Day  0 0 1 0 0 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun at Day5'  Treatment 0 0 1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day  0 0 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun at Day5'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 
                                 Treatment*Day  0 0 0 0 1 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Ultimun at Day5'  Treatment 0 0 1 0 0 -1 0 
                                  Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0   
                                 Treatment*Day  0 0 0 0 1 0 0 0 0 0 -1  
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Day  0 0 0 0 1 0 0 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun at Day5'  Treatment 0 0 0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0  
                                 Treatment*Day  0 0 0 0 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun at Day5'  Treatment 0 0 0 1 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0  
                                 Treatment*Day  0 0 0 0 0 0 1 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 0 0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day  0 0 0 0 0 0 1 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun at Day5'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0  
                                 Treatment*Day  0 0 0 0 0 0 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
                                 Treatment*Day  0 0 0 0 0 0 0 0 1 0 0 0 -1  
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun at Day5'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1    
                                    Treatment*Day  0 0 0 0 0 0 0 0 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Kphi 400 at Aphanidermatum at Day 21'  Treatment 1 -1 0 0 0 0 0 
                                    Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 0 1 0 -1 
                                 Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Max 100 at Aphanidermatum at Day 21'  Treatment 1 0 -1 0 0 0 0 
                                    Treatment*Fungus 1 0 0 0 0 0 -1 
                                    Treatment*Day 0 1 0 0 0 -1 
                                 Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'  Treatment 1 0 0 
-1  
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 0 1 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum at Day 21'  Treatment 1 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 0 1 0 0 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs at Testigo at Aphanidermatum at Day 21'  Treatment 1 0 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 
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                                 Treatment*Fungus*Day  0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs at ZMnPhi 200 at Aphanidermatum Day 21'  Treatment 1 0 0 0 0 0 -1   
                                    Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                    Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Max 100 at Aphanidermatum at Day 21'  Treatment 0 1 -1 0 0 0 0 
                                    Treatment*Fungus 0 0 0 1 0 0 -1  
                                    Treatment*Day 0 0 0 1 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'  Treatment 0 1 0 
-1 0 0 0 
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1  
                                    Treatment*Day  0 0 0 1 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum at Day 21'  Treatment 0 1 0 0 -1 0 0 
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 0 1 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day  0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum at Day 21'  Treatment 0 1 0 0 0 -1 0 
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1  
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum at Day 21'  Treatment 0 1 0 0 0 0 -1  
                                    Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 -1  
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'  Treatment 0 0 
1 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 1 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum at Day 21'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 -1 /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum at Day 21'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum at Day 21'  Treatment 0 0 1 0 0 0 -
1 
                                 Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0  
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 -1   
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum at Day 21'  Treatment 0 0 
0 1 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 -1/oddsratio alpha=0.00238 cl; 
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ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum at Day 21'  Treatment 0 0 0 1 
0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum at Day 21'  Treatment 0 
0 0 1 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0   
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum at Day 21'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0   
                                 Treatment*Day 0 0 0 0 0 0 0 0  0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum at Day 21'  Treatment 0 0 0 0 1 0 -
1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum at Day 21'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0    
                                    Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular at Day 21'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 -1  
                                 Treatment*Day 0 1 0 -1   
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                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular at Day 21'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at at Irregular at Day 21'  Treatment 1 0 0 -1 0 0 
0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular at Day 21'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0  
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Irregular at Day 21'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0   
                                    Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular at Day 21'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 0 1 0 -1     
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular at Day 21'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day 0 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular at Day 21'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Irregular at Day 21'  Treatment 0 1 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 0 1 0 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular at Day 21'  Treatment 0 0 1 -1 0 0 
0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0    
                                 Treatment*Day 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular at Day 21'  Treatment 0 0 1 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0    
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 -1     
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                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Irregular at Day 21'  Treatment 0 0 1 0 0 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 0 0 1 0 0 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0   
                                 Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular at Day 21'  Treatment 0 0 0 1 -1 0 
0 
                                  Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular at Day 21'  Treatment 0 0 0 1 0 -1 0 
                                    Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0  
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 0 0 0 1 0 0 
-1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Irregular at 21'  Treatment 0 0 0 0 1 -1 0 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 
108 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 0 0 0 0 1 0 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular at Day 21'  Treatment 0 0 0 0 0 1 -1 
                                 Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0    
                                 Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs. Kphi 400 at Ultimun at Day 21'  Treatment 1 -1 0 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                 Treatment*Day 0 1 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun at Day 21'  Treatment 1 0 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 0 1 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun at Day 21'  Treatment 1 0 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 
                                    Treatment*Day 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun at Day 21'  Treatment 1 0 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 -1     
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                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs Testigo at Ultimun at Day 21'  Treatment 1 0 0 0 0 -1 0 
                                 Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 
                                 Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 1 0 0 0 0 0 -1 
                                    Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                    Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -1     
                                 Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun at Day 21'  Treatment 0 1 -1 0 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0   
                                 Treatment*Day  0 0 0 1 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun at Day 21'  Treatment 0 1 0 -1 0 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0  
                                 Treatment*Day  0 0 0 1 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -
1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun at Day 21'  Treatment 0 1 0 0 -1 0 0 
                                 Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0  
                                    Treatment*Day  0 0 0 1 0 0 0 0 0 -1    
                                 Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs Testigo at Ultimun at Day 21'  Treatment 0 1 0 0 0 -1 0 
                                Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0  
                                   Treatment*Day  0 0 0 1 0 0 0 0 0 0 0 -1    
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                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 0 1 0 0 0 0 -1 
                                Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                                Treatment*Day  0 0 0 1 0 0 0 0 0 0 0 0 0 -1    
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun at Day 21'  Treatment 0 0 1 -1 0 0 
0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0  
                                Treatment*Day  0 0 0 0 0 1 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
/oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun at Day 21'  Treatment 0 0 1 0 -1 0 0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 
                                Treatment*Day  0 0 0 0 0 1 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs Testigo at Ultimun at Day 21'  Treatment 0 0 1 0 0 -1 0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0   
                                Treatment*Day  0 0 0 0 0 1 0 0 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 0 0 1 0 0 0 -1 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                Treatment*Day  0 0 0 0 0 1 0 0 0 0 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun at Day 21'  Treatment 0 0 0 1 -1 0 0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0  
                                Treatment*Day  0 0 0 0 0 0 0 1 0 -1  
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                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun at Day 21'  Treatment 0 0 0 1 0 -1 0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0  
                                Treatment*Day  0 0 0 0 0 0 0 1 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 0 0 0 1 0 0 
-1 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1  
                                   Treatment*Day  0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun at Day 21'  Treatment 0 0 0 0 1 -1 0 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0  
                                Treatment*Day  0 0 0 0 0 0 0 0 0 1 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 0 0 0 0 1 0 -1 
                                Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
                                Treatment*Day  0 0 0 0 0 0 0 0 0 1 0 0 0 -1  
                                Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun at Day 21'  Treatment 0 0 0 0 0 1 -1 
                               Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1   
                                  Treatment*Day  0 0 0 0 0 0 0 0 0 0 0 1 0 -1  
                               Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 /oddsratio alpha=0.00238 cl; 
run; 
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data allNoTestigo; 
set allpredictors; 
if treatment="Testigo" then delete; 
if treatment="MnPhi 200" then treatment="ZMnPhi200"; 
run; 
proc glimmix data=allNoTestigo method=laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ; 
random Dish(treatment Fungus); 
run; 
proc glimmix data=allNoTestigo method = laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ; 
run; 
 
data MnPhi200ToZMnPhi200; 
 set allpredictors; 
 if treatment="Testigo" then delete; 
 if treatment="MnPhi 200" then treatment="ZMnPhi 200"; 
run; 
     
proc glimmix data=MnPhi200ToZMnPhi200 method = laplace; 
class treatment Day Severity Fungus Dish; 
model Severity=Treatment|Day|Fungus  / solution ;      
ESTIMATE 'Kphi 200  vs Kphi 400 at Aphanidermatum at Day 5'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 -1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Fungus*Day 1 0 0 0 0 0 -1/oddsratio 
alpha=0.00238 cl;   
ESTIMATE 'Kphi 200  vs Max 100 at Aphanidermatum at Day 5'    
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                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio 
alpha=0.00238 cl; 
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'    
                                      Treatment 1 0 0 -1   
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1         
                                      Treatment*Day 1 0 0 0 0 0 -1      
                                      Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
1/oddsratio alpha=0.00238 cl;   
ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum at Day 5'    
                                      Treatment 1 0 0 0 -1  
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1      
                                      Treatment*Day 1 0 0 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;    
ESTIMATE 'Kphi 200  vs at Testigo at Day 5'    
                                      Treatment 1 0 0 0 0  
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs at ZMnPhi 200 at Day 5'    
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Max 100 at Aphanidermatum at Day 5'    
                                      Treatment 0 1 -1 0 0 0 
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                                      Treatment*Fungus 0 0 0 1 0 0 -1            
                                      Treatment*Day 0 0 1 0 -1        
                                      Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 -1/oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1         
                                      Treatment*Day 0 0 1 0 0 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -
1/oddsratio alpha=0.00238 cl;   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum at Day 5'    
                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1      
                                      Treatment*Day 0 0 1 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum at Day 5'    
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0    
                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum at Day 5'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1   
                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum at Day 5'    
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 
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                                      Treatment*Day 0 0 0 0 1 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -
1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum at Day 5'    
                                      Treatment 0 0 1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0   
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                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 0 0 0 0 0 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 1 0 0 0 0 0/oddsratio alpha=0.00238 cl;  
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 1 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum at Day 5'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular at Day 5'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 0 1 0 0 -1              
                                      Treatment*Day 1 0 -1          
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                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 -1/oddsratio 
alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular at Day 5'    
                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 -1        
                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 -
1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at at Irregular at Day 5'    
                                      Treatment 1 0 0 -1 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 -1      
                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
-1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular at Day 5'    
                                      Treatment 1 0 0 0 -1 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 -1/oddsratio alpha=0.00238 cl;  
ESTIMATE 'Kphi 200  vs Testigo at Irregular at Day 5'    
                                      Treatment 1 0 0 0 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
 ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular at Day 5'    
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
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                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
   
 ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular at Day 5'    
                                      Treatment 0 1 -1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 1 0 -1        
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 -1                       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular at Day 5'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 1 0 0 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
-1                 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular at Day 5'    
                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1     
                                      Treatment*Day 0 0 1 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 -1           
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Testigo at Irregular at Day 5'    
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0    
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                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular at Day 5'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular at Day 5'    
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
-1                 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular at Day 5'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 -1           
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs Testigo at Irregular at Day 5'    
                                      Treatment 0 0 1 0 0 0 
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                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular at Day 5'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular at Day 5'    
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 -1           
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular at Day 5'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular at Day 5'    
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                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs Testigo at Irregular at Day 5'    
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 1 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular at Day 5'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 1 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular at Day 5'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 -1     
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Kphi 200  vs. Kphi 400 at Ultimun at Day5'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 -1          
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 -1                            
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun at Day5'    
                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 -1        
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1                      
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun at Day5'    
                                      Treatment 1 0 0 -1 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 -1      
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 -1                
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun at Day5'    
                                      Treatment 1 0 0 0 -1 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 -1          
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Testigo at Ultimun at Day5'    
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                                      Treatment 1 0 0 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 1 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun at Day5'    
                                      Treatment 0 1 -1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 1 0 -1        
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1                      
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun at Day5'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 1 0 0 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 -1                
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun at Day5'    
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                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 1 0 0 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 -1          
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Testigo at Ultimun at Day5'    
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 1 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun at Day5'    
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 -1      
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 -1                
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun at Day5'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 -1          
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs Testigo at Ultimun at Day5'    
                                      Treatment 0 0 1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 1 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun at Day5'    
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 -1    
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 -1          
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun at Day5'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 1 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 0 0 0 0 0 0 -1    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun at Day5'   
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 1 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 0 0 1 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 1 0 0 0 0 0 -1    
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                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun at Day5'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 -1  
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Kphi 400 at Aphanidermatum at Day 21'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 -1         
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 -1                           
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Max 100 at Aphanidermatum at Day 21'    
                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 1 0 0 0 0 0 -1            
                                      Treatment*Day 0 1 0 0 0 -1       
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1                     
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'    
                                      Treatment 1 0 0 -1   
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 -1         
                                      Treatment*Day 0 1 0 0 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 -1               
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Kphi 200  vs MnPhi 400 at Aphanidermatum at Day 21'    
                                      Treatment 1 0 0 0 -1  
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 -1      
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 -1         
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs at Testigo at Day 21'    
                                      Treatment 1 0 0 0 0  
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs at ZMnPhi 200 at Day 21'    
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Max 100 at Aphanidermatum at Day 21'    
                                      Treatment 0 1 -1 0 0 0 
                                      Treatment*Fungus 0 0 0 1 0 0 -1            
                                      Treatment*Day 0 0 0 1 0 -1       
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1                     
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 -1         
                                      Treatment*Day 0 0 0 1 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 -1               
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Aphanidermatum at Day 21'    
                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 -1      
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 -1         
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Testigo at Aphanidermatum at Day 21'    
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0    
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Aphanidermatum at Day 21'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1   
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
130 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Aphanidermatum at Day 21'   
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 -1               
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 400 at Aphanidermatum at Day 21'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 -1         
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs Testigo at Aphanidermatum at Day 21'    
                                      Treatment 0 0 1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Aphanidermatum at Day 21'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1 
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                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Aphanidermatum at Day 21'   
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 1 0 0 0 0 0 -1         
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Aphanidermatum at Day 21'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 1 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Aphanidermatum at Day 21'    
                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs Testigo at Aphanidermatum at Day 21'    
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
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                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Aphanidermatum at Day 21'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Testigo  vs ZMnPhi 200 at Aphanidermatum at Day 21'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Kphi 400 at Irregular at Day 21'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 0 1 0 0 -1              
                                      Treatment*Day 0 1 0 -1         
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 -1                          
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Maxim 100 at Irregular at Day 21'    
                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 
133 
                                      Treatment*Day 0 1 0 0 0 -1       
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1                    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at at Irregular at Day 21'    
                                      Treatment 1 0 0 -1 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 -1              
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 400 at Irregular at Day 21'    
                                      Treatment 1 0 0 0 -1 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1        
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Testigo at Irregular at Day 21'    
                                      Treatment 1 0 0 0 0 0 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Irregular at Day 21'   
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
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                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Maxim 100 at Irregular at Day 21'    
                                      Treatment 0 1 -1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 1 0 -1       
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1                    
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Irregular at Day 21'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 1 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 -1              
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Irregular at Day 21'    
                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 -1     
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1        
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Testigo at Irregular at Day 21'    
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0    
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                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Irregular at Day 21'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Irregular at Day 21'    
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 -1              
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 400 at Irregular at Day 21'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 -1        
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs Testigo at Irregular at Day 21'    
                                      Treatment 0 0 1 0 0 0 
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                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Irregular at Day 21'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Irregular at Day 21'    
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 0 0 0 0 0 -1        
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Irregular at Day 21'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Irregular at Day 21'    
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                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs Testigo at Irregular at 21'    
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 1 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Irregular at Day 21'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Testigo  vs ZMnPhi 200 at Irregular at Day 21'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1  
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Kphi 200  vs. Kphi 400 at Ultimun at Day 21'    
                                      Treatment 1 -1 0 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 -1         
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 -1                         
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Maxim 100 at Ultimun at Day 21'    
                                      Treatment 1 0 -1 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 -1       
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1                   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 200 + Maxim at Ultimun at Day 21'    
                                      Treatment 1 0 0 -1 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 -1             
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs MnPhi 400 at Ultimun at Day 21'    
                                      Treatment 1 0 0 0 -1 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 -1       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs Testigo at Ultimun at Day 21'    
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                                      Treatment 1 0 0 0 0 0 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 200  vs ZMnPhi 200 at Ultimun at Day 21'    
                                      Treatment 1 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 1 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Maxim 100 at Ultimun at Day 21'    
                                      Treatment 0 1 -1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 1 0 -1       
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1                   
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 200 + Maxim at Ultimun at Day 21'    
                                      Treatment 0 1 0 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 1 0 0 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 -1             
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs MnPhi 400 at Ultimun at Day 21'    
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                                      Treatment 0 1 0 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 -1       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs Testigo at Ultimun at Day 21'   
                                      Treatment 0 1 0 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Kphi 400  vs ZMnPhi 200 at Ultimun at Day 21'    
                                      Treatment 0 1 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 1 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs MnPhi 200 + Maxim at Ultimun at Day 21'    
                                      Treatment 0 0 1 -1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 -1     
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 -1             
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'Maxim 100  vs MnPhi 400 at Ultimun at Day 21'    
                                      Treatment 0 0 1 0 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 -1       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs Testigo at Ultimun at Day 21'    
                                      Treatment 0 0 1 0 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Maxim 100  vs ZMnPhi 200 at Ultimun at Day 21'    
                                      Treatment 0 0 1 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 1 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs MnPhi 400 at Ultimun at Day 21'    
                                      Treatment 0 0 0 1 -1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 -1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 1 0 0 0 0 0 -1       
                           /oddsratio alpha=0.00238 cl;  
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ESTIMATE 'MnPhi 200 + Maxim  vs Testigo at Ultimun at Day 21'    
                                      Treatment 0 0 0 1 0 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 1 0 0 0 0 0 0       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 200 + Maxim  vs ZMnPhi 200 at Ultimun at Day 21'   
                                      Treatment 0 0 0 1 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 0 1 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 -1 
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs Testigo at Ultimun at Day 21'    
                                      Treatment 0 0 0 0 1 0 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1   
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1       
                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'MnPhi 400  vs ZMnPhi 200 at Ultimun at Day 21'    
                                      Treatment 0 0 0 0 1 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 1 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 -1 
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                           /oddsratio alpha=0.00238 cl;  
   
ESTIMATE 'Testigo  vs ZMnPhi 200 at Ultimun at Day 21'    
                                      Treatment 0 0 0 0 0 -1 
                                      Treatment*Fungus 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Day 0 0 0 0 0 0 0 0 0 0 0 -1 
                                      Treatment*Fungus*Day 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 
                           /oddsratio alpha=0.00238 cl;    
run; 
 
data MnPhi200ToZMnPhi200; 
 set allpredictors; 
 if treatment="MnPhi 200" then treatment="ZMnPhi 200"; 
run; 
/* combined Severity 0 =A, 1+2+3=B, 4+5=C  */ 
data LessCategories; 
set MnPhi200ToZMnPhi200; 
if severity <1 then smallsev='A'; 
else if severity <=3 then smallsev='B'; 
else smallsev='C'; 
run; 
 
 proc print data=lesscategories; 
run; 
 
 proc glimmix data=LessCategories method=laplace; 
class treatment Day Severity smallsev Fungus Dish; 
model smallsev=Treatment|Day|Fungus  / solution ; 
random Dish(Treatment Fungus) ; 
run;    
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/* combined Severity 0+1+2+3=A, 4+5=B  */   
 data LessCategories; 
 set MnPhi200ToZMnPhi200; 
 if severity <=3 then smallsev='A'; 
 else smallsev='B'; 
run; 
proc print data=lesscategories; 
run; 
 proc glimmix data=LessCategories method=laplace; 
class treatment Day Severity smallsev Fungus Dish; 
model smallsev=Treatment|Day|Fungus  / solution ; 
random Dish(Treatment Fungus) ; 
run; 
proc glimmix data=LessCategories method=laplace; 
      class treatment Day smallsev fungus Dish; 
      model smallsev=Treatment|Day|Fungus  / solution dist=Binomial link=logit; 
     random Dish(Treatment fungus) ; 
run; 
 title 'Fixed model with 3 categories of Severity'; 
proc glimmix data=LessCategories method=laplace; 
 class treatment Day Severity smallsev Fungus Dish; 
 model smallsev=Treatment|Day|Fungus  / solution ; 
 run; 
 title 'Fixed model with 2 categories of Severity'; 
proc glimmix data=LessCategories method=laplace; 
 class treatment Day Severity smallsev Fungus Dish; 
 model smallsev=Treatment|Day|Fungus  / solution ; 
run; 
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Appendix C - SAS Code Power Analysis 
/* Power for Several Simulated Data Sets */ 
 
/* THE MULTINOMIAL DRAWS MODIFIES  
SAS Blog 
 Simulate from the multinomial distribution in the SAS DATA step 
By Rick Wicklin on The DO Loop, March 16, 2016 */ 
 
%let SampleSize = 10; /* number of observations in MN sample */ 
%let N = 5; /* number of trials in each MN draw */ 
%let categ = 6; /* number of categories in each MN draw */ 
%let Ntreat = 7; /* number of treatments */ 
 
%macro Simul(N_B=, seed=); 
data MN; 
 call streaminit(&seed); 
 
 /* prob of drawing items */ 
 array probs{&Ntreat, &categ} _temporary_ (0 0 0 0 0.05 0.95 0.3 0.5 0.2 0 0 0  
  0.1 0.1 0.1 0.1 0.3 0.3 0.15 0.8 0.05 0 0 0 0.05 0.45 0.45 0.05 0 0 0 0 0 0.1  
  0.75 0.15 0 0 0.1 0.75 0.15 0); 
 array x{&categ}; 
 
 /* counts for each item */ 
 do trt=1 to &Ntreat; 
 
  do dish=1 to &SampleSize; 
   ItemsLeft=&N; /* how many items remain? */ 
   cumProb=0; /* cumulative probability */ 
   do i=1 to &categ-1;/* loop over k categories */ 
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    if ItemsLeft=0 or cumProb=1 then 
     do; 
      x[i]=0; 
     end; 
    else 
     do; 
      p=probs[trt, i] / (1 - cumProb); 
 
      if p >=1 then 
       x[i]=ItemsLeft; 
      else if p < 1 then 
       do; 
        x[i]=rand("binomial", p, ItemsLeft); 
/* binomial draw */ 
       end; 
      cumProb=cumProb + probs[trt, i]; /* adjust prob of 
next binomial draw */ 
      ItemsLeft=ItemsLeft - x[i]; /* decrement size by 
selection */ 
     end; 
   end; 
   x[&categ]=ItemsLeft; /* remaining items go into last category */ 
   output; 
  end; 
 end; 
 keep trt dish x:; 
run; 
 
proc transpose data=MN out=power1 name=raiting; 
 by trt dish; 
 var x:; 
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run; 
 
/* Runs the first simulation outside the Loop to create the output DataSets */ 
 
proc glimmix data=power1 method=laplace; 
 class trt raiting dish; 
 freq col1; 
 model raiting(order=data)=trt /dist=multinomial solution; 
 *random intercept /subject=dish(trt) solution; 
 *parms (0.01) / hold=1; 
 contrast 'ctr v exp 1' trt 1 -1; 
 contrast 'ctr v exp 2' trt 1 0 -1; 
 contrast 'ctr v exp 3' trt 1 0 0 -1; 
 contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
 contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
 contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
 contrast 'exp 1 v exp 2' trt 0 1 -1; 
 contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
 contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
 contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
 contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
 contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
 contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
 contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
 contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
 contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
 contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
 contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
 contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
 contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
 contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
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 ods output tests3=F_overall contrasts=F_contrasts; 
run; 
 
data powerFIXED; 
 set F_overall F_contrasts; 
 Simul=0; 
run; 
 
proc glimmix data=power1 method=laplace; 
 class trt raiting dish; 
 freq col1; 
 model raiting(order=data)=trt /dist=multinomial solution; 
 random intercept /subject=dish(trt) solution; 
 parms (0.1) / hold=1; 
 contrast 'ctr v exp 1' trt 1 -1; 
 contrast 'ctr v exp 2' trt 1 0 -1; 
 contrast 'ctr v exp 3' trt 1 0 0 -1; 
 contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
 contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
 contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
 contrast 'exp 1 v exp 2' trt 0 1 -1; 
 contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
 contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
 contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
 contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
 contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
 contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
 contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
 contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
 contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
 contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
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 contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
 contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
 contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
 contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
 ods output tests3=F_overall contrasts=F_contrasts; 
run; 
 
data powerMIXEDLARGE; 
 set F_overall F_contrasts; 
 simul=0; 
run; 
 
proc glimmix data=power1 method=laplace; 
 class trt raiting dish; 
 freq col1; 
 model raiting(order=data)=trt /dist=multinomial solution; 
 random intercept /subject=dish(trt) solution; 
 parms (0.01) / hold=1; 
 contrast 'ctr v exp 1' trt 1 -1; 
 contrast 'ctr v exp 2' trt 1 0 -1; 
 contrast 'ctr v exp 3' trt 1 0 0 -1; 
 contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
 contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
 contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
 contrast 'exp 1 v exp 2' trt 0 1 -1; 
 contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
 contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
 contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
 contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
 contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
 contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
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 contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
 contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
 contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
 contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
 contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
 contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
 contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
 contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
 ods output tests3=F_overall contrasts=F_contrasts; 
run; 
 
data powerMIXEDSMALL; 
 set F_overall F_contrasts; 
 simul=0; 
run; 
 
 %do b=1 %to &N_B; 
 
  data MN; 
   call streaminit(&seed&b); 
 
   /* prob of drawing items */ 
   array probs{&Ntreat, &categ} _temporary_ (0 0 0 0 0.05 0.95 0.3 0.5 0.2 
0 0  
    0 0.1 0.1 0.1 0.1 0.3 0.3 0.15 0.8 0.05 0 0 0 0.05 0.45 0.45 0.05 0 0 
0 0 0  
    0.1 0.75 0.15 0 0 0.1 0.75 0.15 0); 
   array x{&categ}; 
 
   /* counts for each item */ 
   do trt=1 to &Ntreat; 
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    do dish=1 to &SampleSize; 
     ItemsLeft=&N; /* how many items remain? */ 
     cumProb=0; /* cumulative probability */ 
     do i=1 to &categ-1; /* loop over k categories */ 
      if ItemsLeft=0 or cumProb=1 then 
       do; 
        x[i]=0; 
       end; 
      else 
       do; 
        p=probs[trt, i] / (1 - cumProb); 
 
        if p >=1 then 
         x[i]=ItemsLeft; 
        else if p < 1 then 
         do; 
          x[i]=rand("binomial", 
p, ItemsLeft); /* binomial draw */ 
         end; 
        cumProb=cumProb + probs[trt, i]; /* 
adjust prob of next binomial draw */ 
        ItemsLeft=ItemsLeft - x[i]; /* 
decrement size by selection */ 
       end; 
     end; 
     x[&categ]=ItemsLeft; /* remaining items go into last 
category */ 
     output; 
    end; 
   end; 
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   keep trt dish x:; 
  run; 
 
  proc transpose data=MN out=power1 name=raiting; 
   by trt dish; 
   var x:; 
  run; 
 
  proc glimmix data=power1 method=laplace; 
   class trt raiting dish; 
   freq col1; 
   model raiting(order=data)=trt /dist=multinomial solution; 
   *random intercept /subject=dish(trt) solution; 
   *parms (0.01) / hold=1; 
   contrast 'ctr v exp 1' trt 1 -1; 
   contrast 'ctr v exp 2' trt 1 0 -1; 
   contrast 'ctr v exp 3' trt 1 0 0 -1; 
   contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
   contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
   contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
   contrast 'exp 1 v exp 2' trt 0 1 -1; 
   contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
   contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
   contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
   contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
   contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
   contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
   contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
   contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
   contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
   contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
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   contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
   contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
   contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
   contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
   ods output tests3=F_overall contrasts=F_contrasts; 
  run; 
 
  data powerFIXED0; 
   set F_overall F_contrasts; 
   Simul=&b; 
  run; 
 
  proc glimmix data=power1 method=laplace; 
   class trt raiting dish; 
   freq col1; 
   model raiting(order=data)=trt /dist=multinomial solution; 
   random intercept /subject=dish(trt) solution; 
   parms (0.1) / hold=1; 
   contrast 'ctr v exp 1' trt 1 -1; 
   contrast 'ctr v exp 2' trt 1 0 -1; 
   contrast 'ctr v exp 3' trt 1 0 0 -1; 
   contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
   contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
   contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
   contrast 'exp 1 v exp 2' trt 0 1 -1; 
   contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
   contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
   contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
   contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
   contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
   contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
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   contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
   contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
   contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
   contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
   contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
   contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
   contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
   contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
   ods output tests3=F_overall contrasts=F_contrasts; 
  run; 
 
  data powerMIXEDLARGE0; 
   set F_overall F_contrasts; 
   simul=&b; 
  run; 
 
  proc glimmix data=power1 method=laplace; 
   class trt raiting dish; 
   freq col1; 
   model raiting(order=data)=trt /dist=multinomial solution; 
   random intercept /subject=dish(trt) solution; 
   parms (0.01) / hold=1; 
   contrast 'ctr v exp 1' trt 1 -1; 
   contrast 'ctr v exp 2' trt 1 0 -1; 
   contrast 'ctr v exp 3' trt 1 0 0 -1; 
   contrast 'ctr v exp 4' trt 1 0 0 0 -1; 
   contrast 'ctr v exp 5' trt 1 0 0 0 0 -1; 
   contrast 'ctr v exp 6' trt 1 0 0 0 0 0 -1; 
   contrast 'exp 1 v exp 2' trt 0 1 -1; 
   contrast 'exp 1 v exp 3' trt 0 1 0 -1; 
   contrast 'exp 1 v exp 4' trt 0 1 0 0 -1; 
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   contrast 'exp 1 v exp 5' trt 0 1 0 0 0 -1; 
   contrast 'exp 1 v exp 6' trt 0 1 0 0 0 0 -1; 
   contrast 'exp 2 v exp 3' trt 0 0 1 -1; 
   contrast 'exp 2 v exp 4' trt 0 0 1 0 -1; 
   contrast 'exp 2 v exp 5' trt 0 0 1 0 0 -1; 
   contrast 'exp 2 v exp 6' trt 0 0 1 0 0 0 -1; 
   contrast 'exp 3 v exp 4' trt 0 0 0 1 -1; 
   contrast 'exp 3 v exp 5' trt 0 0 0 1 0 -1; 
   contrast 'exp 3 v exp 6' trt 0 0 0 1 0 0 -1; 
   contrast 'exp 4 v exp 5' trt 0 0 0 0 1 -1; 
   contrast 'exp 4 v exp 6' trt 0 0 0 0 1 0 -1; 
   contrast 'exp 5 v exp 6' trt 0 0 0 0 0 1 -1; 
   ods output tests3=F_overall contrasts=F_contrasts; 
  run; 
 
  data powerMIXEDSMALL0; 
   set F_overall F_contrasts; 
   simul=&b; 
  run; 
 
  data powerFIXED; 
   set powerFIXED powerFIXED0; 
  run; 
 
  data powerMIXEDLARGE; 
   set powerMIXEDLARGE powerMIXEDLARGE0; 
  run; 
 
  data powerMIXEDSMALL; 
   set powerMIXEDSMALL powerMIXEDSMALL0; 
  run; 
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 %end; 
%mend; 
 
%let SampleSize = 10; /* number of observations in MN sample */ 
%let N = 5; /* number of trials in each MN draw */ 
%let categ = 6; 
%let Ntreat = 7; 
 
%Simul(N_B=1000, seed=36457); 
 
libname fungus "/home/USERNAME”; /*Setting the LIBNAME directory to Save the Results*/ 
 
data fungus.powerFIXED&SampleSize&N; 
 set powerFIXED; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
data fungus.powerMIXEDLARGE&SampleSize&N; 
 set powerMIXEDLARGE; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
data fungus.powerMIXEDSMALL&SampleSize&N; 
 set powerMIXEDSMALL; 
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 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
 
%let SampleSize = 10; /* number of observations in MN sample */ 
%let N = 10; /* number of trials in each MN draw */ 
%let categ = 6; 
%let Ntreat = 7; 
 
%Simul(N_B=1000, seed=36457); 
 
data fungus.powerFIXED&SampleSize&N; 
 set powerFIXED; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
data fungus.powerMIXEDLARGE&SampleSize&N; 
 set powerMIXEDLARGE; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
data fungus.powerMIXEDSMALL&SampleSize&N; 
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 set powerMIXEDSMALL; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
 
%let SampleSize = 20; /* number of observations in MN sample */ 
%let N = 5; /* number of trials in each MN draw */ 
%let categ = 6; 
%let Ntreat = 7; 
 
%Simul(N_B=1000, seed=36457); 
 
data fungus.powerFIXED&SampleSize&N; 
 set powerFIXED; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
data fungus.powerMIXEDLARGE&SampleSize&N; 
 set powerMIXEDLARGE; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
159 
data fungus.powerMIXEDSMALL&SampleSize&N; 
 set powerMIXEDSMALL; 
 nc_parm=numdf*Fvalue; 
 alpha=0.00238; 
 F_Crit=Finv(1-alpha, numdf, dendf, 0); 
 Power_F=1-probF(F_crit, numdf, dendf, nc_parm); 
run; 
 
 
 
 
 
